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Abstract 
Sepsis is an excessive inflammatory response to infection that leads to multiple organ failure. 
The high mortality rates in the intensive care unit have remained stagnant, which can be 
attributed to the disconnect between the bench and the bedside. There is a global need for an 
animal model of sepsis that is more relevant to the clinical scenario. We developed an in vivo 
rat model of sepsis, with a high level of instrumentation, to monitor macrovascular and 
microvascular changes over the course of a feces-induced peritonitis (FIP).  
In addition, early fluid resuscitation of septic patients is associated with better clinical 
outcomes; however, the type of fluid used for resuscitation is highly disputed. The first 
application of our in vivo model was to use clinical resuscitation targets to test the effect of 
fluid type (crystalloid or colloid) on both the microvasculature and the systemic circulation.  
Keywords: sepsis, feces-induced peritonitis, colloid, crystalloid, microcirculation 
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Chapter 1  
Introduction and Background 
1.1  Thesis Outline 
This thesis was motivated by the needs of ICU physicians, and sepsis researchers alike, to 
provide a well-controlled animal model that is representative of human sepsis. The 
disparity between the bench and the bedside has been brought to light recently, due to the 
failure of several clinical trials aimed at improving the survivability of sepsis. The aim of 
this model was to provide a platform to test common ICU interventions, and attempt to 
explicate the impact of these interventions on the microvascular environment surrounding 
the vital organs. The difficulties in developing a working animal model of sepsis that has 
clinical applications furthered our understanding of the complexity of the sepsis state, and 
made clear the challenges of translational research. These difficulties are minor, however, 
when compared to the difficulty in understanding the human sepsis condition given the 
multitude of potentially confounding variables, routes of infection, and patient 
backgrounds.  
This thesis is divided into four chapters. The first chapter provides an introduction to the 
current state of sepsis in the ICU, and the issues surrounding translating bench-side 
research to clinical practice. It also summarizes current therapies aimed at restoring 
macrovascular and microvascular circulation. This chapter further outlines the issues with 
current animal models of sepsis, and highlights some important aspects of an “ideal” 
translational model.  
The second chapter outlines the development of an animal model of sepsis that is more 
clinically relevant. In collaboration with ICU physicians, we demonstrate our two-sided 
(macrovascular and microvascular) instrumentation techniques, which provide data 
similar to what would be available in the critical care environment. To illustrate the 
similarity in acquired measurements, this chapter also shows sample data collected from 
a septic animal. 
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The third chapter of this thesis demonstrates an application of our model addressing a 
common debate among clinicians as to which fluid should be used for resuscitation. This 
experiment was guided by clinical resuscitation targets, and aimed to elucidate the 
mechanistic effect of different fluids on microvascular restoration in sepsis. Two of the 
most common fluids used clinically, saline and albumin, were tested as the first 
application of the model. This chapter provides preliminary data for each fluid type used 
for resuscitation, and illustrates the associated microvascular effect of achieving 
hemodynamic optimization targets.  
The final chapter provides a critical discussion of experimental findings, and explores 
potential additions to improve the fidelity of the model. Lastly, this chapter explores 
possible future applications of our model.  
1.2  Sepsis 
Sepsis is a systemic inflammatory response to infection that causes a wide range of 
clinical conditions in an unpredictable manner. The pathogenesis of sepsis can involve 
multiple organ systems, and is characterized by an initial inflammatory phase comprised 
of increased cardiac output, low systemic vascular resistance, and heterogeneity of 
microvascular blood flow, depleted blood volume due to increased vascular permeability, 
and decreased blood pressure[1, 2]. This is followed by an immunosuppression phase, 
which involves decreased cardiac output, low systemic vascular resistance, and 
respiratory distress in tissue cells, tissue edema, and indications of hypoxia within the 
vital organs. The progression of sepsis is rapid, the symptoms between patients are 
inconsistent, the site of infection is variable, and the timing of intervention is critical to 
survivability[3-6]. For this reason, despite major improvements in the quality of patient 
care, sepsis mortality rates have remained stagnant. 
A landmark epidemiology study analyzing the healthcare burden of severe sepsis in the 
United States, demonstrated that the cost of sepsis to the healthcare system in 1995 was 
$16.7 billion annually, with over 800,000 diagnosed cases. [5]. With an associated 
mortality rate of 30%, sepsis was the leading cause of death in the intensive care unit. 
Despite an increased knowledge of the pathophysiology of sepsis, the mortality rate of 
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patients with severe sepsis remains stagnant. Over 70 multi-center clinical trials have 
been implemented, aimed at improving the survivability of sepsis, and most of them 
failed to show a positive survival benefit[7].This can be attributed to the difficulty in 
defining sepsis, and the degree of disconnect between the bench and the bedside[7, 8]. It 
has also recently been recognized that consideration of the microcirculation in sepsis may 
lead to improved survivability[9].  
1.3  The Microcirculation in Sepsis 
The microcirculation (vessels <100µm in diameter) is responsible for transporting oxygen 
and nutrients to tissue cells and, if needed, delivers therapeutics. This network of 
arterioles, capillaries, and post-capillary venules form the microcirculatory unit that is 
severely affected in sepsis. Within this network, endothelial cells line the inside of the 
vessels, and smooth muscle cells regulate arteriolar tone, while red blood cells, 
leukocytes, platelets and plasma form the components of the blood[10]. The transport of 
oxygen occurs primarily at the capillary level, and involves passive diffusion of oxygen 
from the arterioles and the capillaries to the surrounding environment[11]. This system is 
highly regulated and, in healthy individuals, has the ability to distribute blood flow to 
meet the unique oxygen requirements of each tissue. In sepsis, the microvascular system 
is compromised, and oxygen transport to the vital organs is severely affected. The 
restoration of tissue perfusion is intimately linked to survival in sepsis[12]. 
The microcirculatory alterations common in sepsis include: an increase in the amount of 
stopped flow capillaries, maldistribution of oxygen delivery to tissue, increases in 
arteriolar diameter, and increased spatial distance between perfused capillaries for 
oxygen diffusion[1, 13, 14].  Within this network, endothelial cell swelling, leukocyte 
trafficking and stiffness, disruption of vascular tone regulation, stiff red blood cells, and 
fibrin/platelet clotting can lead to stopped flow in capillaries, and further compromised 
tissue function[15, 16].  
The early septic response in humans is associated with a hypodynamic phase in which 
there is an imbalance between the oxygen demands of tissue, and the necessary supply to 
maintain proper organ function. This leads to global tissue hypoxia, and the recognition 
4 
 
of this phase incites early goal-directed therapy implementations aimed at optimizing 
systemic hemodynamic parameters in an attempt to restore tissue oxygenation[3]. Despite 
this optimization, microcirculatory perfusion can remain impaired [17, 18]. It follows that 
compromised microvasculature common to sepsis, and the associated hypoxic conditions 
in tissue, initiates a cascade of pathogenic mechanisms that could eventually result in 
organ failure[10]. The relationship between impaired oxygen extraction and mortality in 
sepsis has been known for decades; however, the emergence of bedside technology 
allowing for the observation of patient microcirculation has illustrated the importance of 
considering the microcirculatory environment given the pivotal role it plays in sepsis- 
induced organ dysfunction [10, 12, 15, 16, 19]. For this reason, goal-directed therapies 
aimed at re-establishing macrovascular homeostasis exclusively may be insufficient in 
restoring microcirculatory flow in the tissues of septic patients and thus do not prevent 
organ failure [20, 21].  
It is well known that heterogeneous distribution of blood flow in sepsis causes some 
capillaries to be under perfused, while some capillaries remain normal or highly 
perfused[13]. This maldistribution of blood flow greatly increases the diffusion distance 
of oxygen in the capillary bed, which can quickly cause hypoxic conditions. The low 
levels of mixed-venous oxygen saturation, and high lactate levels at the onset of sepsis, 
are indicative of this response. The production of lactate is indicative of anaerobic 
metabolism, which is related to tissue hypoxia, due to decreased oxygen extraction[22]. 
Lactate could also increase due to mitochondrial failure, or due to abnormalities in 
pyruvate dehydrogenase activity[23, 24]. The decrease in oxygen extraction ratio despite 
increased cardiac output in the hyperdynamic phase of sepsis could be due to impaired 
mitochondrial respiration, reducing the utilization of available oxygen[25]. On the other 
hand, it could also be due to heterogeneity of flow caused by microvascular injury, which 
causes inadequate oxygen supply to some regions of tissue[1, 26].  
Endothelial cells play an important role in sensing flow, and have the ability to transmit 
upstream information about the downstream microcirculatory conditions[27]. These cells 
also have regulatory properties that control microvascular tone, permeability and 
capillary recruitment, as well as controlling coagulation and immune function[28]. In 
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sepsis, the endothelial cells do not function properly, which causes loss of cell-to-cell 
communication and smooth muscle control. The dysfunction of endothelial cells in sepsis 
thus has a marked effect on microcirculatory perfusion. Endothelial-cell-mediated 
microvascular dysfunction causes arteriolar vasodilation, leukocyte adhesion, 
microvascular permeability, compromised cell-to-cell communication, altered functional 
capillary density, maldistribution of capillary blood flow, and abnormal oxygen transport 
and tissue oxygenation[1, 10, 20, 27]. Furthermore, erythrocytes are also affected in 
sepsis and become less deformable, which affects their ability to release nitric oxide in 
the presence of hypoxia to cause a vasodilatory response[29]. Taken together, the 
microvascular environment is dysfunctional, leading to a severe decrease in peripheral 
vascular resistance, tissue edema, myocardial and multiple organ microvascular 
dysfunctions.  
It is not clear whether or not therapeutic interventions (e.g. fluid resuscitation, 
vasodilators, vasopressors) aimed at improving global oxygen delivery to tissue will be 
effective if there is not an increase in microvascular recruitment and flow. A major focus 
of this thesis was to utilize imaging techniques to quantify the degree of microvascular 
failure in the capillary bed of an animal throughout the onset of an applied septic insult. 
Dual-wavelength intra-vital video microscopy provided the unique ability to measure 
velocity, supply rate, hematocrit, and oxygen saturation for single capillaries, which 
illustrates the mechanistic effect of microvascular dysfunction in sepsis.  
1.3.1  Microcirculatory Monitoring in the ICU 
It is well established that a poorly functioning microvascular system leads to multiple 
organ failure and poor prognosis in sepsis[30]. Despite therapies aimed at re-establishing 
macrovascular homeostasis and improving global oxygen delivery (fluid resuscitation, 
vasopressors, inotropic agents, vasodilators, blood transfusions), the inability to re-
perfuse hypoxic capillary beds renders these interventional techniques ineffective[10, 
31]. The ability to assess the degree of microvascular dysfunction in the ICU is thus a 
valuable tool to provide insight into the severity of sepsis, and the environment 
surrounding the vital organs[32]. 
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Laser-Doppler, and forearm ischemia reperfusion techniques can measure regional 
microvascular alterations; however, these methods do not take heterogeneity of flow into 
account, which leads to underestimation of the severity of microvascular dysfunction in 
sepsis[33]. In order to address the need for observation of the microvasculature at the 
bedside, side-stream dark field (SDF) imaging was developed and can be implemented in 
critically ill patients[10]. This technique consists of a 530-nm light source, a wavelength 
that is absorbed by hemoglobin within erythrocytes, allowing for the viewing of flowing 
cells in the sublingual vascular bed. The images obtained using SDF imaging can be 
analyzed post capture to determine the severity of microvascular dysfunction. Briefly, the 
images are separated into quadrants and capillaries are categorized based on RBC transit 
to obtain a measure of perfusion quality. In addition, dividing the image by 3 vertical and 
3 horizontal lines, and determining the number of vessels that cross these lines, is a 
determinant of vessel density[34].  
While SDF imaging has demonstrated correlations with severity in sepsis, it is not 
without limitations. The measurements made using this technique illustrate the degree of 
perfusion within the observed network; however, there has been no demonstrated ability 
to extract oxygen saturation data within the perfused capillaries. Furthermore, the 
technique is very sensitive to motion and pressure artifacts, and it is thus difficult to 
observe the exact same network over a period of time[34]. Also, the wavelength of light 
used in this technique does not allow for good contrast between the red blood cells and 
the capillary lumen[11], which is subject to inter-observer variability due to qualitative 
assessment of perfusion. The relevance of alterations in sublingual perfusion in a 
heterogeneous disease state such as sepsis have not been shown to be a definitive 
indicator of septic onset, and until more objective measurement tools are available, 
should only act as a secondary marker of the progression of microvascular failure in 
sepsis. 
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1.4  Overview of Clinical Sepsis Diagnostic Criteria 
One of the major challenges in diagnosing sepsis in global ICUs has been due to lack of a 
precise definition of sepsis[6]. In addition, patients in the ICU often suffer from 
comorbidities, which cause a largely heterogeneous array of symptoms.  
Table 1-1 provides the criteria most commonly used to diagnose systemic inflammatory 
response, and illustrates the flow of criteria used to identify sepsis.  
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Diagnostic	  Criteria	  	   	  
Systemic	  Inflammatory	  Response	  Syndrome	  (SIRS)	  
Core	  temperature	  >38oC	  or	  <36oC	  
Heart	  rate	  >	  90	  beats/min	  
Respiratory	  rate	  >20	  breaths/min	  or	  PaCO2	  <32	  mmHg	  	  White	  blood	  cell	   count	  >	  12,000	  cells/mm3	  or	  <	  4,000	  cells/mm3	   or	   differential	   showing	   10%	   immature	  (band)	  neutrophils	  
Sepsis	  :	  2	  or	  more	  of	  SIRS	  +	  proven/suspected	  infection	  
Documented	  infection	  
Perforated	  viscous	  
Syndrome	  associated	  with	  a	  high	  likelihood	  of	  infection	  	  
	   Bacteria	  in	  a	  normally	  sterile	  fluid	  
	   Evidence	  of	  pneumonia	  with	  purulent	  sputum	  
Severe	  Sepsis:	  	  Sepsis	  +	  Evidence	  of	  organ	  dysfunction	  	  
Cardiovascular	   –	   Use	   of	   vasopressors	   or	   systolic	   BP	  <90mmHg	   or	   MAP<70	   mmHg	   despite	   fluid	  resuscitation	  
Renal:	  urine	  output	  <0.5ml/kg/hr	  	  
Respiratory:	  mechanical	  ventilation	  or	  PaO2/FiO2	  <	  250	  mmHg	  
	   Hematologic:	  platelet	  count	  <	  80,000	  cells/mm3	  
Table 1-1 Criteria used to diagnose a septic patient [6, 8, 35]. This table illustrates 
common physiological parameters that are used to diagnose a patient as septic.   
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1.5  Early Goal-Directed Therapy in Sepsis 
While there is difficulty in adequately defining sepsis, early recognition and associated 
intervention is associated with improved survivability. The ability to recognize sepsis in 
the early stages of the disease, when treatment would be most effective, is difficult. As 
sepsis develops, hypovolemia, myocardial depression, increased metabolism and loss of 
vasoregulation create an imbalance between oxygen supply and demand by the vital 
organs[36]. Organ dysfunction quickly ensues, and if unrecognized, leads to increased 
mortality in the early phase of septic onset[37].  Due to perturbations in systemic 
circulation, the body is not able to match oxygen supply to demand, and attempts to 
compensate by increasing oxygen extraction, which consequently leads to a decrease in 
mixed venous oxygen. This in turn, leads to increased lactate production as the oxygen 
extraction limit is reached, which is a hallmark of early sepsis. The early-phase 
recognition of sepsis is the primary target of early goal-directed therapies aimed at 
preventing the dysfunction cascade that progresses very rapidly once it is initiated. 
The systemic parameters that are relied upon to diagnose sepsis in the early phase are 
usually CVP, MAP, and lactate levels. The monitoring of these parameters is standard 
practice in the clinical setting, and allows for early identification of patients at risk of 
becoming septic. Early goal-directed therapy involves aggressive fluid resuscitation in an 
attempt to increase intravascular volume, venous saturations, and to optimize systemic 
hemodynamic parameters (CVP, MAP)[36]. It has been shown that fluid therapy in the 
early phase of sepsis has a survival benefit, which is the reason that resuscitation is very 
common, and identification of an ideal fluid for resuscitation is important[38]. The 
drawback of early goal-directed therapy is that achievement of systemic targets does not 
directly indicate restoration of the microcirculatory environment; oxygen delivery and 
inflammation-mediated perfusion impairment may still persist, resulting in local tissue 
hypoxia.  
1.5.1  Resuscitation Fluids 
The primary goal of resuscitation fluids and early goal-directed therapy is to restore the 
intravascular volume of hypovolemic patients [39]. Choice of fluid type for resuscitation 
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is highly debated amongst ICU physicians; however, early administration of fluids is 
associated with decreased mortality[3]. Two of the most commonly used fluids for 
resuscitation are saline and albumin, and there have been several studies and meta-
analyses (SAFE, CRYCO, Delaney (Meta-analysis), Cochrane Group (Meta-Analysis)) 
that have attempted to determine which resuscitation fluid best improves mortality in 
sepsis, to no avail[40-43]. One potential explanation of this consistent discrepancy is due 
to the variability in patient recruitment within these clinical trials. The presence of co-
morbidities and the timing of sepsis diagnosis vary greatly in the ICU, which makes 
interpreting the efficacy of resuscitation fluid inherently difficult.  
Mechanistically, a bolus injection of fluid into the venous system for fluid resuscitation 
takes advantage of the Frank-Starling mechanism, by increasing right arterial pressure, 
leading to increased cardiac output. The bolus injection increases venous return by 
increasing systemic pressure due to volume increase, which causes increased flow to the 
right heart. In addition, the large volumes of fluid administered in resuscitation regimens 
result in the hemodilution of the blood. This reduces the resistance of the blood in the 
circulation due to slightly decreased viscosity, which is another reason that cardiac output 
and venous return increase[44]. 
Physiologically, the main difference between albumin and saline is that albumin 
generates colloid osmotic pressure (COP), or oncotic pressure, which is responsible for 
drawing water into the vasculature. COP is inversely proportional to extravascular fluid 
flux, thus maintaining intravascular volume[45]. Albumin is able to maintain COP due to 
the Van’t Hoff’s equation: 
 
𝑂𝑠𝑚𝑜𝑡𝑖𝑐  𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒   𝜋 = 𝑅𝑇𝑐𝑀 + 𝑘𝑐! (1) 
 
Where R is the universal gas constant, T is the temperature, M is the molecular mass of 
the substance, c is the concentration, and k is a constant. From this equation it can be 
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deduced that osmotic pressure is proportional to concentration, and inversely proportional 
to molecular mass. Albumin is the major contributor of oncotic pressure in the blood as it 
has the smallest molecular weight (69kD) of all the plasma proteins, and it is the most 
abundant. The osmotic effect of albumin is further increased by its negative charge, 
which causes attraction of cationic molecules into the intravascular environment[46].  
Saline on the other hand is not able to maintain osmotic pressure, and causes dilution of 
the oncotic agents in the normal blood plasma. Thus saline resuscitation leads to 
decreased COP, causing increased filtration of water across the capillary membrane. This 
causes a greater increase in interstitial fluid than intravascular volume, and illustrates 
why higher volumes of saline would be required to achieve the same degree of 
intravascular volume expansion as albumin. 
A comparison of physiological characteristics between 5% albumin and saline is 
provided (Table 1-2). In addition to osmotic pressure, albumin has a number of 
potentially protective roles, especially within compromised microvasculature. Albumin 
decreases the permeability of the vasculature, and decreases the leakage of fluid by down 
regulation of vascular inflammation. Though the exact mechanism is not known, the 
negative charge of albumin may repel membrane proteins; the size of the albumin 
molecules may reduce the size of endothelial pores thereby reducing vascular leak.  
The protective effect of albumin is further supported by the finding that albumin plays a 
role in preventing endothelial cell apoptosis which, when considering the microvascular 
dysfunction associated with sepsis, may provide a survival benefit[47]. Albumin has 
anticoagulant effects similar to heparin, and acts to lessen leukocyte-endothelial cell 
interaction and platelet aggregation.  Albumin also has binding capabilities, which allows 
albumin to act as a carrier for antibiotics and many other potential therapeutics[46]. 
Hypoalbuminemia is associated with poor prognosis, and exogenous administration of 
albumin has been found to produce a survival benefit in these patient cohorts. It remains 
unknown whether the lack of albumin in these patients causes poor outcomes, or is 
merely an indicator of a more severe issue[46].  
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The drawbacks of albumin are that it is relatively expensive, and due to the fact that it is 
created by pooled human plasma, has the potential to transmit infection. Furthermore, 
there are some cohorts of patients, such as those present with traumatic brain injury, that 
have significant increases in mortality with albumin resuscitation, such that albumin 
resuscitation should be avoided in these cases.  
The drawback of saline, besides a greater tendency for tissue edema, is the potential for 
hyperchloremic metabolic acidosis. This is caused by an overall decrease in blood pH, 
due to dilution of blood bicarbonate, which would be stimulated by the large amount of 
saline required to achieve resuscitation targets. Hyperchloremic metabolic acidosis 
caused by large volumes of saline resuscitation may cause increased inflammation and 
mortality in sepsis[48].  
Although in theory albumin appears that it would be more effective as a resuscitation 
fluid, high-quality evidence supporting the beneficial effect of albumin is lacking[41]. 
The secondary aim of this thesis was to provide insight into the efficacy of albumin 
versus saline as resuscitation fluids. While many different fluids are still used clinically, 
the decision to begin with 5% human albumin and saline as the first application of our 
model lies in the relevancy to global critical cares. In an animal model with a controlled 
insult, the administration of bolus fluids was implemented in accordance with clinical 
hemodynamic targets to maintain translational integrity.  
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   Colloid	   Crystalloid	  
	   5%	  Albumin	   0.9%	  Saline	  
Molecular	   weight,	   Average	  
(kD)	  
69	   0.06	  
COP,	  mmHg	   20-­‐30	   0	  
Maximum	   Volume	   expansion,	  
%	  
70-­‐100	   20-­‐25	  
Duration	  of	  Volume	  expansion,	  
h	  
12-­‐24	   1-­‐4	  
Potential	  for	  adverse	  reactions	   Low	   Low	  
Possible	  Side	  Effects	  	  	  	  	  
Allergic	  Reactions	   Hyperchloremic	  acidosis	  	  Transmitted	  Infection	  
Table 1-2 Comparison of physiological characteristics of the most commonly used 
colloid and crystalloid fluids for resuscitation[45].  
1 .6  Animal Models of Sepsis 
In critical care research, the importance of animal models that accurately mimic the 
human septic condition is integral in the development of therapeutics, for the 
development of sepsis staging criteria, and to broaden understanding of sepsis 
pathophysiology[49]. The difficulty in carrying out effective research in humans lies in 
the multitude of potentially confounding variables in recruited patient cohorts. The 
presence of comorbidities (e.g. diabetes, pneumonia, myocardial infarction), various 
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sources of initial infection, and concomitant therapeutic interventions, are all sources of 
variability that impede valid conclusions within the clinical research environment[7]. 
Research difficulty is further exacerbated due to the fact that early diagnosis of sepsis is 
based on unspecific criteria, and the progression from SIRS to sepsis can be caused by a 
multitude of pathophysiological pathways[50].  
Although it is difficult to perfectly replicate clinical sepsis, the ability to remove some of 
the variability inherent to clinical human populations using an animal in a controlled 
laboratory environment could be a valuable translational tool. Nevertheless, there is 
currently a lack of clinically relevant animal models of sepsis[51]. This is a contributing 
factor to the failure of so many clinical trials, and is a barrier to the development of 
reliable therapeutics for the treatment of sepsis[7]. Animal models are necessary not only 
in the development of therapeutics, but also in understanding mechanistically how the 
therapeutics may improve patient outcomes and mortality rates [52]. There are several 
fundamental issues with animal models of sepsis that make translating knowledge from 
the bench to the bedside difficult they include: source of induced insult, lack of 
physiological monitoring and intensive care, timing of treatment, lack of co-morbidities, 
and animal type[7, 49, 51-53].  
In an attempt to mimic the human septic condition, several animal models have been 
developed, which can be categorized based on the type of initiated insult. The most 
common infective agents are: exogenous administration of toxin (e.g. lipo-polysaccharide 
(LPS)), exogenous pathogen administration (bacteria), and iii) endogenous disturbance of 
protective barrier against bacteria (e.g. cecal ligation and perforation (CLP))[49]. While 
each model has merits in terms of understanding response to infection, the ability to 
mimic the hemodynamic response in septic patients is essential. The hemodynamic 
response occurs in two distinct phases: the early phase (increased cardiac output, low 
peripheral resistance) and the late phase of hemodynamic shock (decreased cardiac 
output, low peripheral resistance[54]. Besides the disparity in immune response, both 
exogenous toxemia and bacterial infection models are also unable to replicate the human 
hemodynamic response, which limits the clinical applicability of these models. While 
these methods are still commonly used, CLP is considered the gold standard, as this 
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source of infection is able to effectively mimic the hemodynamic conditions attributed to 
the human septic response[2]. A common criticism of animal models is the lack of 
intervention that would ensue in a patient present with the same conditions. The CLP 
model creates necrotic tissue, promoting abscess formation, which would necessitate 
excision in a human patient[49]. The formation of an abscess is a further drawback of the 
CLP model; an animal can stave off the infection, effectually preventing septic onset[2]. 
Furthermore, puncture size and amount of expressed fecal matter causes large variation in 
severity of the infectious stimulus between animals, which decreases the consistency 
necessary to draw effective conclusions from animal experimentation. These issues are 
exacerbated by the lack of physiological monitoring to follow the overall status of the 
animal, and for comparison to output from instrumentation common to ICU patients. 
The lack of intensive care monitoring in animal studies is a major drawback in models of 
sepsis. Septic patients are instrumented such that indicators of macrovascular data (MAP, 
CVP, HR, Respiratory Rate) are continuously monitored, and mechanical ventilation is 
usually necessary[52]. The lack of instrumentation, and thus absence of physiological 
monitoring, is closely associated with inconsistency in interventional techniques. If 
physiological data is not available, both sepsis diagnosis and therapeutic interventions are 
not guided by the same criteria as the clinical setting[53]. This leads to arbitrary 
implementation of interventions, potentially before the animal would be clinically 
considered septic, and creates a further disconnect between the bench and the bedside.  
The lack of co-morbidities in animal models is another common point of criticism. The 
plethora of possible comorbidities in septic patients is misrepresented in animal models, 
and is a very common criticism of translational research [7, 50-52]. While introducing 
co-morbidities into an animal model may improve clinical relevancy, the potential for 
confounding variables is large, and the choice of co-morbidity would still only represent 
a small portion of septic patients. The use of a two-hit model in theory would provide 
valuable information; however, a basic one-hit model needs to first be established in 
order to distinguish the effect of the co-morbidity on the septic response. This is also true 
of therapeutic interventions, higher-level instrumentation, and septic models with longer 
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durations (see Fig. 1-1). The primary aim of this thesis was to develop this central node 
model that can act as a platform for future sepsis studies.  
The use of animals, such as baboons, sheep and pigs is common to sepsis research; 
however, the large cost of these experiments preclude their use in large numbers, which is 
necessary to effectively establish the potential benefit in human patients. In addition to 
cost, these large animals are less sensitive to bacteria than humans, thus posing a 
challenge to translational research. Sheep models of sepsis have illustrated similar 
sensitivity to humans, and replicate the hemodynamic response of sepsis; however, there 
have been few survival studies in sheep, which limits the effectiveness of their use in 
pharmacological research[51]. The use of murine models of sepsis has come into 
question recently due to the discovery that the difference in genomic response to 
inflammation is misrepresentative of the human condition[55]. Also, the small size of 
mice, and low blood volume (~1ml/25g mouse) makes it difficult to fully instrument a 
mouse to monitor global hemodynamic changes throughout sepsis, and regular blood 
sampling is not possible. The larger size of rats, allows for a greater degree of 
instrumentation, and the ability to obtain regular blood samples. Thus far the genomic 
response of rats to septic insult has not been refuted, and based on experimental studies, 
rats phenotypically mimic the hemodynamic changes associated with the human 
response.  
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Figure 1-1 The need for a basic translational animal model of sepsis. The establishment 
of a central node model of sepsis is very important and would form a platform that can be 
altered depending on desired clinical scenario, while maintaining the accuracy and 
integrity of clinical practice. The formulation of this node model is of fundamental 
importance for global critical care research. 
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1.6.1  Design Constraints for a New Sepsis Model 
Given the rationale for a model of sepsis that is more relevant to the clinical scenario, the 
aspects that need to be incorporated in order to be effective relate to macrovascular 
measurements, a window into the microvascular environment, controlled insult, and 
clinical diagnostic criteria. 
Instrumentation that is able to provide systemic data over the entire course of the septic 
response, from implementation of insult to the culmination of the experiment, is essential. 
Choosing an appropriately sized animal to allow for a high degree of instrumentation, 
with minimal invasiveness is a primary first step. The instrumentation should provide 
basic vital sign data (MAP, CVP, HR, and Respiratory Rate), for the duration of the 
experiment. Additional instrumentation will only strength the translational application of 
the developed model, and will allow for a more complete representation of systemic 
parameters, increasing the validity of experimental findings.  
Next, a window into the microvascular environment is important to be able to determine 
the effect that macrovascular perturbations have on the systemic microcirculation. As 
capillaries are the primary area for gas exchange to tissue, the ability to monitor perfusion 
alterations over the course of a septic insult is integral to providing clinically relevant 
data. As qualitative measurements are relied upon clinically, the added ability to make 
quantitative microvascular measurements may provide mechanistic explanations for 
clinical observations. Furthermore, the window into the microvasculature brings a two-
sided approach to septic animal research, allowing for more accurate interpretation of 
results.  
The ability to control the insult between animals is also important to be able to replicate 
the septic response. A major issue in elucidating information clinically is due to the 
variety of patient backgrounds and differing degrees of sepsis severity. For this reason, 
mimicking the response between animals, and in essence, between treatment groups, 
allows the data extracted to be attributed to interventional therapies, and modifications to 
the model, rather than due to variability in the initial insult. 
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Lastly, and most often overlooked is the necessity to monitor the animal after the 
initiation of insult, and to only intervene when the animal would be clinically diagnosed 
as septic. This prevents the animal from being “pre-treated” before the onset of sepsis, 
which could greatly improve survivability, and potentiate misleading conclusions.  
1.7  Objectives and Hypotheses 
This thesis involved two main objectives: 
1) To create an animal model of sepsis, incorporating the rationale for an effective 
translational model 
With the guidance of critical care physicians we aimed to create an animal ICU, for the 
instrumentation of an animal that can be monitored as a human surrogate. We aimed to 
monitor the physiological parameters over the entire course of the septic response, and to 
develop an insult that would mimic the cardiovascular events of human sepsis. We also 
wanted to ensure that our insult was sufficient to create an obvious sepsis diagnostic 
window that would be related to clinical indicators of early sepsis. Lastly we wanted to 
incorporate the use of a microvascular window in an organ remote the site of initial 
inflammation in order to assess the degree of microvascular dysfunction associated with 
our administration of the septic insult.  
2) To test the application of our model by testing the efficacy of different fluid types for 
clinical hemodynamic optimization, and the associated effect on the microvascular 
environment 
We decided to test the two most common resuscitation fluids saline and albumin, due to 
the debate as to which fluid better restores systemic homeostasis and improves 
survivability. As there is not a well-defined way to measure microvascular perfusion 
quantitatively, mortality, and global systemic parameters are relied upon for 
determination of fluid efficacy. The application of our model to test this issue permits 
two-sided data acquisition, allowing for the characterization of fluids based not only on 
global hemodynamic targets, but also on the ability to prevent/restore microvascular 
perfusion. Our goal was to test the efficacy of saline and albumin as resuscitation fluids 
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with respect to optimization of hemodynamic parameters at the macrovascular level, and 
restoration of microvascular perfusion.  
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Chapter 2  
Developing a translational animal model of sepsis 
2.1  Introduction 
Despite global research efforts aimed at improving outcomes in sepsis, the associated 
systemic inflammatory response and multiple organ failure remains the major cause of 
mortality and morbidity [1]. Although understanding of the pathophysiology of sepsis is 
improving, translating the pre-clinical knowledge of sepsis from the bench to the bedside 
remains a major challenge[2]. A recent international roundtable discussion aimed at 
improving clinical trials in the critically ill emphasized the need for a translational animal 
model of sepsis that is more representative of the clinical scenario[3]. The discussion was 
spawned by the failure of over 60 randomized clinical trials, citing the shortcomings of 
previously developed animal models as a major contributing factor. The main issue 
reported in this article is that many animal models fail to consider the physiological status 
of the animal over the entire course of a septic insult. The lack of a clinically relevant 
animal model of sepsis is a major obstacle in terms of developing effective therapies for 
sepsis[4].The failure to use a clinical definition of sepsis to initiate potential therapies 
may also cause misleading conclusions, and thus ineffective translational research. In 
addition, the authors noted that it is important to be able to tightly control an 
experimental system, especially in a heterogeneous disease state such as sepsis. For this 
reason, it is important to choose an animal type, and a route of induced infection that will 
adequately and consistently mimic the human septic response[4-6].  
In terms of replicating human sepsis, it is common to divide the response into two phases: 
early and late sepsis. Early sepsis is often characterized by an increase in cardiac output, 
and low peripheral resistance, whereas late sepsis involves low cardiac output, while still 
exhibiting low peripheral resistance[5]. The difficulty representing the early phase of 
sepsis in an animal model can be attributed to early goal-directed therapies in the clinical 
treatment of septic patients. Clinically, in the early phase of sepsis, a patient has likely 
already received antibiotic and fluid therapy, inducing a hyperdynamic circulatory state. 
As previously mentioned, in creating a clinically relevant animal model of sepsis, it is 
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important to illustrate the baseline effect of a septic response prior to intervention 
implementation. For this reason, short-term animal models of sepsis prior to any 
interventions are more likely to represent the transition from “pre-sepsis” to early phase 
sepsis, which is commonly associated with a drop in cardiac output, and an increase in 
peripheral resistance[7, 8]. Representing this transition phase is important in terms of 
elucidating the mechanistic effect of early-goal directed therapies implemented at the 
time of diagnosis of sepsis. Clinically, peritonitis represents 20-25% of infections leading 
to severe sepsis[9]. Several rat models of septic peritonitis have been established, and the 
response to infection is well documented and understood. For these reasons, the use of a 
peritonitis-based insult serves as a strong foundation for the development of a consistent 
and comprehensive model of clinical sepsis[7, 8, 10, 11]. 
The goal of our study was to create an animal model of sepsis, which involved clinical 
experience from ICU physicians in an effort to create a platform that promotes effective 
translational research. Considering recommendations from the international roundtable 
discussion, as well as input from the Canadian Critical Care Translational Research 
Group, we created a clinically relevant model that closely resembles nosocomial sepsis. 
We present a two-sided approach in the creation of our model in that we have the unique 
ability to measure both macrovascular and microvascular parameters over the entire 
course of a septic response. Intensivists, to ensure clinical accuracy, guided our novel 
approach and the associated diagnostic and instrumentation protocols. Our use of a flow 
probe on the abdominal aorta, as well as a pulse transducer catheter in both the carotid 
artery and jugular vein allow us to accurately measure CO, MAP, HR, and CVP for the 
entire course of our experiment. This high level of instrumentation allows us to 
accurately calculate peripheral resistance, and stroke volume without relying on observer 
tracings of aortic diameters[12]. 
Additionally, we use dual-wavelength intra-vital video microscopy (DλIVVM) to observe 
the microculation in the hindlimb muscle of our animals. Utilizing the differing light 
absorption properties of oxy- and deoxyhemoglobin we are able to elucidate the oxygen 
saturation changes over the course of a septic insult. This measurement technique is 
valuable for validation of our model as we are able to monitor macrovascular and 
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microvascular changes from “pre-sepsis” to early sepsis [13, 14]. A detailed diagram 
illustrating the parallels of our animal model, and a patient in the ICU is provided (Fig. 2-
1). 
This model will act as a stepping-stone for future studies, and can be easily adapted to 
match the ever-evolving demands of critical care research. The aim of this paper is to 
illustrate the capabilities of our animal model by demonstrating our instrumentation, data 
collection, and analysis techniques.  
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Figure 2-1 Parallels between instrumentation of a human patient in the ICU, and our 
animal model. Human heart rate is measured using an electrocardiograph; cardiac output 
is measured using the thermodilution technique via a Swan-Ganz catheter implanted into 
the pulmonary artery, microcirculation is qualitatively assessed using side-stream dark 
field imaging. Animal model instrumentation is described in the methods. 
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2.2  Materials and Methods 
Animal protocols were approved by the Animal Care and Use Committee of the 
University of Western Ontario (see appendix A). Sprague-Dawley rats were used in this 
study; male rats were used exclusively in order to eliminate the effects of the estrous 
cycle[15]. 
2.2.1  Animal Instrumentation 
The rats (100g on delivery) were housed in the animal quarters at the University of 
Western Ontario and acclimatized for 7 days after delivery. On the day of the experiment 
rats were randomized to FIP or sham laparotomy groups, and weighed to verify that their 
mass was within experimental range (170-210g). Animals were anesthetized via 
intraperitoneal injection of sodium pentobarbital (6.5 mg/100g body weight). A rectal 
thermometer was inserted to monitor temperature, and a heat lamp was used to maintain a 
core body temperature of 37oC.The trachea was cannulated to allow mechanical 
ventilation at a rate of 73-76 breaths/min with a flow-controlled air mixture of 
30%O2/70%N2. The left common carotid artery was cannulated with polyethylene tubing 
(I.D. 0.58mm, O.D.0.965mm). The carotid artery cannula allowed heart rate and mean 
arterial pressure to be monitored and recorded via the amplified signal of an attached 
pressure transducer and PowerLab system (model ML118 PowerLab Quad Bridge 
Amplifier; model MLT0699 BP Transducer, ADInstruments, Colorado Springs, CO, 
USA). The right external jugular vein was cannulated using Silastic tubing (I.D.0.64mm, 
O.D. 1.19mm) with a beveled end through which saline (0.9%) was continuously infused 
for minimal fluid resuscitation (0.5 ml saline/h). Supplemental doses of anesthetic were 
delivered via the jugular catheter as needed to maintain sufficient anesthesia for the 
duration of the experiment (7 hours). The jugular vein cannula allowed central venous 
pressure to be monitored and recorded via the amplified signal of an attached pressure 
transducer and associated software (Digi-Med LPA-400, DMSI-200 host software, 
Micro-Med, Louisville, KY). A Transonic perivascular flow probe cuff (2mm, model 
2PSB) was placed on the abdominal aorta between the right iliolumbar artery and the 
right external iliac artery. The flow probe allowed cardiac output to be continuously 
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monitored and recorded via the PowerLab system. The incision was then sutured closed 
in two layers.  
The extensor digitorum longus (EDL) muscle was blunt dissected and externalized as 
previously described[16]. Briefly, a small section of skin was excised from the lateral 
side of the right hindlimb in order to expose the underlying fascia capsule. Superficial 
dissection of the capsule and blunt separation of the surrounding muscle allowed the EDL 
to be separated from the surrounding muscle tissues. Once isolated, silk ligature was 
threaded beneath both the intact muscle, and the attached distal portion of the EDL 
tendon and secured with a square knot. The tendon was severed between the knot and 
EDL muscle insertion, leaving the ligature securely attached to the free end of the EDL 
tendon. After EDL dissection, the animal was transferred to the microscope stage and 
placed in a supine position. The midline stitches were removed, and peritonitis was 
induced via intraperitoneal injection of autologous feces (FIP) (0.3 ml/100g rat of fecal 
slurry (1.5g feces in 1.5 ml saline)). The FIP slurry was made fresh prior to the start of 
instrumentation. The sham procedure consisted of removing the midline stiches, and 
injection of mock-FIP (0.3 ml/100g saline) into the abdominal cavity. See Appendix C. 
The incision was then sutured closed in two layers and the animal placed in the right 
lateral decubitus position. The ligature attached to the EDL tendon was placed on the 
microscope stage such that the lateral side of the muscle faced the objective lenses. The 
ligature was then taped to maintain a length and angle approximate to the in situ position 
of the muscle. The muscle was moistened with 37°C saline (0.9%) and covered on the 
medial side with a small rectangle of plastic film (2 1 cm, polyvinylidene chloride, Saran) 
and a glass coverslip sealed with vacuum grease to isolate the muscle from the external 
environment. 
2.2.2  Dual Wavelength Intra-Vital Video Microscopy 
The acquisition system was composed of an Olympus IX81 inverted microscope 
(Olympus objective X20/0.75 numerical aperture) fitted with a 75W xenon lamp to 
transilluminate the muscle, a beamsplitter (Photometrics-DC2) with a filter cube 
containing interference filters at wavelengths 442-nm and 454-nm, and two Q-Imaging 
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Rolera-XR digital video cameras attached to the beamsplitter. Adjustments on the beam 
splitter made it possible to register the two images and make them parfocal for 
simultaneous video capture at the two wavelengths. After allowing the muscle to 
equilibrate (30 minutes) real-time microvascular blood flow video sequences (696 X 520, 
21 frames/second) were taken of in-focus capillaries within the EDL muscle. The videos 
captured at the wavelengths (442-nm and 454-nm) were chosen to utilize the unique 
light-absorption properties of oxy- and deoxyhemoglobin similar to the previously 
described system[17]. The 454-nm wavelength is an isosbestic wavelength, whereas 
absorption at the 442-nm wavelength changes with oxygen saturation.  
2.3  Experimental Protocol 
2.3.1  Video Recordings 
After the intraperitoneal injection (baseline), the physiological status of the animal was 
continuously monitored, as previously outlined. Microvascular blood flow video 
sequences were taken of in-focus capillaries in 10 distinct fields of view. Recordings 
were made at baseline (after equilibration), 3 hours, and 5 hours post-injection.  
2.3.2  Blood Samples 
After the video sequences were recorded 250μl of heparinized arterial blood was 
collected (baseline, 3, 5 hours). Once the sample was collected the blood volume was 
replaced with heparinized saline. To measure systemic blood variables, an iSTAT point-
of-care system was used, along with associated cartridges (CG4+: Lactate, blood gases, 
CG8+: Na, K, iCa, Gluc, Hct, blood gases).  
A timeline representation of the above methodology is provided (Fig. 2-2). 
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Figure 2-2 Timeline of study for animal model. Blue arrows indicate the timing of video 
captures, as well as timing of blood collection. Red asterisk indicates administration of 
FIP, and BL indicates the timing of baseline measurement collection. The animal is 
minimally resuscitated with an infusion of saline (0.9%, 0.5 ml/hr). MAP, HR, CVP, and 
CO are measured for the entire observation period. 
2.3.3  Video Processing and Functional Images 
At the culmination of the experiment, the recorded video sequences were processed and 
stored as uncompressed 16-bit PNG files using custom capture software (Neovision). The 
video sequences from both wavelengths were processed using Matlab algorithms, as 
previously described, which produce functional images[18]. These images allowed 
delineation of hemodynamic and O2 saturation measurements for individual capillaries, 
using custom software developed in our lab. Briefly, the functional images allow the 
software to accurately determine the coordinates of the lumen of the selected capillaries, 
as well as the centerline of the vessel. Once the vessel is traced, light intensity levels 
along the centerline of the vessel are extracted over the sample interval producing space-
time images (STIs), one for each wavelength. Measurement of average velocity, O2 
saturation, RBC supply rate, hematocrit, and diameter were made from the analysis of the 
33 
 
STIs. All in-focus vessels, from each field of view, at each timepoint, were analyzed 
using the same technique. A total of 16 in focus capillaries were analyzed in the hindlimb 
muscle of the presented animal. See Appendix B. 
2.3.4  Functional Capillary Density Measurement 
Capillary densities were determined from the captured video sequences by counting the 
number of capillaries that crossed three staggered overlaid test lines (200μm	   each)	  
perpendicular to the direction of the EDL muscle fibers	  as	  described	  previously[14]. A 
total of three staggered test lines were overlaid for each recorded field perpendicular to 
the direction of the EDL muscle fibers. The capillaries that intersected the test line were 
categorized over a 30 second interval based on the degree of RBC transit as either: 
continuous, intermittent, or stopped. A capillary was considered continuous if the flow 
was uninterrupted over the sequence, intermittent if flow had at least 3 seconds of 
stopped flow, or had a period of reversed flow direction, or stopped if the capillaries did 
not have any flow over the course of the recorded video sequence. Capillaries that did not 
have RBC’s were not included in capillary density measurement. Capillary density was 
counted for each field of view, at each time point, and averaged to determine the change 
in capillary density over the course of the septic response. In the presented data, 10 fields 
of view were measured to determine functional capillary density. 
2.3.5  Physiological Data Analysis 
The physiological data collected for the duration of the experiment were analyzed using 
LabChart software. A moving average was used to analyze the collected variable signals 
(MAP, CVP, CO, HR). A 300 second (5 minute) averaging window was chosen, and the 
average of each interval was taken over the course of the experiment (5 Hours). This was 
done to eliminate major deviations within the signal in order to extract the physiological 
effect of the insult alone. Stroke volume (CO x HR) and total peripheral resistance 
(MAP-CVP/CO) were calculated at the culmination of the experiment.  
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2.3.6  Physiological Variables 
The clinical adaptability of our model lies in the parameters we can continuously 
monitor. Comparing the microvascular data to the macrovascular data facilitates a better 
understanding of the underlying pathophysiology of the septic response.  
2.3.7  Statistical Analysis 
Microvascular data and functional capillary density measurements are presented as mean 
and standard deviation. The data presented are for one (n=1) demonstration animal, thus 
analysis for statistical significance was not performed. 
2.4  Results 
2.4.1  Animals 
Examples of arterial blood measurements from a single septic animal demonstrating the 
global measurements collected over the course of a septic insult are found in Table 2-1. 
The systemic parameters were measured at 3 time points to track the progression over the 
course of the experiment. 
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   Hct	  (%)	   Lactate	  (mmol/L)	   Glucose	  (mmol/L)	  
Baseline	   0.43	   1.51	   10.3	  
3	  Hours	   0.45	   1.06	   9.4	  
5	  Hours	   0.46	   2.7	   3.2	  
	   pH	  
pCO2	  
(mmHg)	   pO2	  (mmHg)	  
Baseline	   7.438	   37.9	   113	  
3	  Hours	   7.437	   34.1	   128	  
5	  Hours	   7.353	   38.6	   108	  
Table 2-1 Systemic variables at baseline, 3 hours, and 5 hours. All measurements were 
made from heparinized arterial blood collection, immediately following video capture.  
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Figure 2-3 Macrovascular measurements from baseline to 5 hours post insult of (A) 
Heart Rate (B) MAP (C) Cardiac Output (D) CVP, (E) Stroke Volume* and (F) Total 
Peripheral Resistance* (n=1). The superimposed line on the blood pressure graph 
indicates clinical sepsis inclusion criteria (<75mmHg). See Appendix C. In this example, 
our diagnosis of sepsis occurs around the 3.5-hour timepoint. * = Calculated   
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Figure 2-4 Microvascular quantification of capillary A) Oxygen Saturation, B) 
Hematocrit, C) Velocity and D) Supply rate (n=16 capillaries). 
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Figure 2-5 Functional capillary density for baseline, 3-hour and 5-hour time points to 
quantitatively measure the degree of microvascular dysfunction. Analyzed capillaries are 
categorized as either continuous flow, intermittent flow, or stopped flow capillaries based 
on degree of RBC transit. Values correspond to the number of capillaries in each 
category that cross the 600-µm test line. (n=10 fields of view) 
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2.5  Discussion 
This study presents a novel model of sepsis that is more clinically relevant, as the high 
degree of instrumentation provides continuous macrovascular data, while concurrently 
providing a window of the microvasculature to assess the degree of dysfunction. 
Furthermore, our use of FIP to induce sepsis allowed us to obtain systemic measurements 
immediately following the initiation of insult (true baseline). The success of translating 
animal studies to the bedside depends on the ability to effectively document the severity 
of sepsis at the time of intervention. One of the main pitfalls of translational animal 
research is the inability to monitor the septic response over the entire course of the 
experiment. Thus our dual-sided approach addresses the major drawbacks of previous 
animal models, and will ultimately provide insight into the mechanistic effects of 
interventional therapies. 
Clinically the efficacy of a treatment intervention will be affected by the severity of the 
insult. Thus the information provided by the microcirculation is integral to determining 
the severity of sepsis as it relates to the severity of dysfunction of the vital organs. 
Currently, the sublingual microcirculation is the only easily accessible clinical 
microcirculation that is used in an attempt to quantify changes in the microcirculation in 
response to sepsis. While this technique provides qualitative information regarding 
microcirculatory dysfunction, due to inherent technical limitations it is not currently 
possible to make oxygen saturation measurements, and thus provides little insight into the 
degree of oxygen delivery to tissues. For this reason, the microcirculatory window in our 
model provides valuable information that allows determination of indices of oxygen 
delivery to the tissues. It is our hypothesis that severity of organ dysfunction of sepsis 
relates to the inability to deliver adequate oxygen to the organ tissues as a result of 
microcirculatory dysfunction. 
In terms of the recommendations from the roundtable discussion, the challenge of animal 
models lies in the difficulty in representing the complexity of clinical sepsis, alluding to 
the absence of models that focus on co-morbidities. Our model is a fundamental first step 
towards addressing this problem. It is of critical importance when developing a model of 
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human disease to have control over the entire protocol. The establishment of a reliable 
foundation increases the adaptability of the model, and provides a workable baseline such 
that the effect of modifications will be easy to detect. For example, with our established 
model, using an aged animal would not require any modifications to our protocol, and the 
effect of age on macrovascular and microvascular response to sepsis can be clearly 
defined. In addition, our model does represent a simple two-hit model, as the surgical 
procedure in instrumenting the animal requires invasive surgery. The surgical aspect of 
our protocol, however, is minimal and therefore more predictable in terms of 
inflammatory response of the animal (due to surgery). Taken together with the addition of 
a septic insult, our model effectively represents clinical nosocomial sepsis arising 
secondary to an initial trauma.  
Utilizing FIP to induce sepsis also has distinct advantages over the use of endotoxin 
administration or cecal ligation methods. Firstly, although CLP is considered the “gold 
standard” in sepsis research, the procedure still introduces an inflammatory response 
within the peritoneum, which can be variable depending upon the degree of fecal 
contamination at the time of surgery, and whether or not abscess formation ensues [19]. 
The surgical process of ligating the cecum also takes considerable time, and delays data 
acquisition to the extent that “baseline” measurements may be obtained up to an hour 
after the initial insult (see Appendix C). Further, the inflammatory responses to intra-
abdominal abscess may also be variable which is dependent upon ability to contain the 
infected area. While the size or number of punctures can somewhat control animal 
mortality, the variability of fecal contamination is the major source of variability in the 
severity of the insult between animals[5]. The use of the FIP technique introduces a 
higher level of control, as the dose can be adjusted depending on the desired severity of 
insult. In addition, the use of autologous fecal matter provides a similar type of insult to 
that of a CLP without the creation of an additional inflammatory response from the 
surgical intervention. Furthermore, it also mimics a clinical scenario of fecal 
contamination of the peritoneum following gut perforation. 
Another recommendation of the roundtable is that animal models provide insight into the 
mechanism of action of targeted therapeutics. In order to better predict the response of 
41 
 
septic patient to therapies, in vivo demonstration of physiological responses to an 
intervention is imperative. Once again our model is able to successfully address this 
concern due to our two-sided approach and the introduction of a true baseline in a septic 
animal model. As therapeutics are often given based on a patient fulfilling distinct 
inclusion criteria, the degree of instrumentation in our model would allow us to treat our 
septic animals in the same fashion. The development of our model was driven by ICU 
physicians in order to ensure that the future applications of this model to treatment 
strategies have significant clinical representation. Besides the macrovascular data, the 
concomitant microvascular information our model provides is of utmost importance. 
While many clinical therapeutics target macrovascular endpoints, knowing the associated 
effect on the microvasculature can provide valuable mechanistic information. For 
example, fluid resuscitation strategies generally target MAP as an endpoint; however, it is 
still unknown what macrovascular targets are the best predictors of improving oxygen 
delivery to the microcirculation and if implementing microvascular endpoints of various 
therapies may augment survivability. The demonstration animal in this study was 
minimally resuscitated (0.5 ml/saline/hr) in order to illustrate the macrovascular effect of 
the septic insult exclusively without the addition of fluid therapy.  
The absence of continuous flow vessels at the 5-hour time point in figure 2-5 does not 
affect our ability to make velocity and oxygen saturation measurements post experiment. 
The processing software only requires that there is flow in the vessel at some point during 
the video capture sequence. For this reason data can be extracted from intermittent flow 
vessels even though they may have periods of stopped or reversed flow. 
As closely as we have represented the clinical scenario, however, there are limitations 
and potential additions that could improve the integrity of our model. In this model, we 
rely upon MAP to indicate septic onset, as we already have a documented source of 
infection; however, there are several other metrics utilized clinically that we are unable to 
measure in our model. Firstly, urine output is commonly used to assess adequacy of fluid 
resuscitation and to some degree, kidney dysfunction, which is a common indicator of 
early sepsis. While it is possible to catheterize a rat, the technique is far more invasive 
and complex than the same process in a human patient. Furthermore, the use of 
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pentobarbital anesthetic suppresses the central nervous system, preventing passive 
urinary flow. Due to the already invasive nature of our protocol, we chose not to 
catheterize the bladder; however we could adapt our protocol to include this measurement 
in the future. See Appendix C. Additional criteria that are used in diagnosis of clinical 
sepsis include heart rate, and timing before requirement of mechanical ventilation. Our 
choice of pentobarbital anesthetic requires mechanical ventilation early on in the surgical 
procedure, prior to administration of the septic insult. While other anesthetics more 
readily promote natural breathing, which would allow us to include time until mechanical 
ventilation requirement, pentobarbital has the least interfering effect on the 
cardiovascular parameters that are a strength of our model[20]. Furthermore, heart rate > 
90 bpm is used clinically as an indicator of early sepsis. It is difficult to use rat heart rate 
as a reliable indicator of sepsis as the heart rate of a rat is 6 to 7 times greater than that of 
a human, and there is a large amount of innate variability in the heart rate signal. For this 
reason we do not use heart rate as an indicator of systemic sepsis. Next, we present an 
acute model of sepsis in that the septic response we instigate is monitored for 5 hours. 
While the ability to completely mimic a human septic response would last several days, 
our microcirculatory preparation is terminal. In order to completely duplicate the timing 
of a human response we would have to sacrifice our microcirculatory data collection, 
which is a pivotal advantage our model has over previous animal models.  
In terms of adding to our model, harvesting the vital organs at the culmination of our 
experiment could identify markers and pathological injury of sepsis, and would act to 
bolster the relevance of our model to the clinical scenario. Next, measuring white blood 
cell count, platelet, and creatinine levels would be a simple addition that would improve 
the clinical relevancy of our model. Lastly, utilizing other techniques, such as near-
infrared spectroscopy, to assess the microvascular environment surrounding easily 
accessible vital organs (brain, kidney etc.), would reinforce our use of the EDL as 
representative vital organ vasculature.  
In summary, our model presents a valuable tool in translational research, with an 
abundance of potential applications. The model has many moving parts that can easily be 
modified to meet the demands of critical care, and sepsis researchers alike. The model 
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also serves as a valuable learning tool for clinicians with our unique ability to illustrate 
the systemic affect of therapeutic interventions.  
2.6  Conclusion 
The presented model achieved our goal of creating a translational animal model, guided 
by ICU physicians, that is representative of a clinical septic response. In addressing the 
recommendations of the international roundtable discussion on animal research in sepsis, 
we created a well-defined, repeatable model with a high level of control over the severity 
of insult. This model lays the groundwork for future studies aimed at elucidating the 
effects of interventional techniques such as fluid resuscitation, and impact of early goal-
directed therapies on the microvascular environment. 
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Chapter 3  
Assessing fluid resuscitation efficacy in a translational 
animal model of sepsis 
3.1  Introduction 
The systemic inflammation induced by sepsis poses significant challenges to the 
circulatory system and causes local regions of hypoxia in the vital organs[1]. The fast 
progression of this disease is associated with the imbalance between oxygen delivery and 
oxygen demand, which leads to multiple organ failure, and high mortality rates in the 
ICU[2]. The imbalance is due to a multitude of circulatory effects including 
hypovolemia, myocardial depression, peripheral vasodilation, and increased tissue 
metabolism[3]. It is well established that early recognition of sepsis leads to better 
clinical outcomes, and improved survivability[4]. Early goal-directed therapy guided by 
physiological targets is fundamental to improving patient outcomes, and administration 
of fluids for resuscitation is often the first strategy to be implemented[3]. As of yet, there 
is no “gold standard” fluid used for resuscitation, and there is constant debate among 
clinicians as to which type of fluid best restores macrovascular and microvascular 
targets[5]. Saline and albumin, two of the most commonly used resuscitation fluids, are at 
the center of this debate. Several clinical trials and meta-analyses have attempted to 
demonstrate conclusive evidence of an ideal resuscitation fluid; however, the findings, 
much like the opinions of clinicians, were mixed[6-8]. While clinical trials and meta-
analyses are able to involve large cohorts of patients, there are several sources of 
variability inherent to patient recruitment that make it difficult to draw definitive 
conclusions. Variability in patient background, concomitant therapies, timing of sepsis 
diagnosis, and timing of intervention, all contribute to these discrepancies[9]. For this 
reason, elucidating the actual mechanistic effect of fluid type on resuscitation is 
intrinsically difficult. Furthermore, although fluid resuscitation strategies often target 
global hemodynamic parameters, the mortality rate of sepsis remains relatively stagnant. 
Recently, it has been shown that the macrocirculation and the microcirculation may be 
differentially regulated in sepsis, which further demonstrates the need for considering the 
effect of early goal-directed therapies on the microcirculatory environment[10-12]. The 
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lack of evidence of fluid efficacy using translational animal models of sepsis only 
exacerbates these pitfalls, defining a clear disconnect between the bench and the bedside.  
Using our previously developed animal model of sepsis we are able to test the effect of 
fluid administration on both the macrovascular and microvascular environment, over the 
entire course of a septic response. In active collaboration with the Canadian Critical Care 
Translational Research Group, and awareness of the PRECISE study, we decided to test 
the effect of the most common resuscitation fluids: 0.9% saline, and 5% albumin[13]. 
There are currently no clinical guidelines that determine the use of one resuscitation fluid 
over the other, thus comparing the efficacy of each fluid is a reasonable first application 
of our model.  
Saline is the most commonly used resuscitation fluid. Its purpose is to increase or 
maintain vascular volume, however saline does not have the ability to maintain osmotic 
pressure, and readily leaks into the extravascular environment. For this reason, a higher 
volume of saline is generally required to maintain hemodynamic optimization[14].  
We used 5% human albumin in accordance with common clinical concentrations. 
Albumin is used as a resuscitation fluid since it maintains colloid osmotic pressure 
(COP), which limits extravascular leakage[15]. Albumin also has anti-inflammatory 
properties, prevents platelet aggregation, and may play a role in maintenance of 
endothelial cell function[16].  
The goal of this study was to utilize clinically relevant hemodynamic optimization 
targets, in conjunction with our previously developed translational animal model of 
sepsis, to determine the macrovascular and microvascular consequence of saline and 
albumin as resuscitation fluids. We utilize dual wavelength intra-vital video microscopy 
(DλIVVM) to provide a window into the microvasculature, in an organ remote to the site 
of septic insult, that allows us to monitor the progression of microvascular dysfunction at 
the onset of sepsis. This gives us the unique ability, in conjunction with a fully 
instrumented animal, to provide physiological data similar to a patient in the ICU, with 
the addition of a quantitative measurement of microvascular perfusion and oxygen 
transport. While the sublingual microcirculation is relied upon clinically to assess 
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microvascular perfusion, the measurement process is semi-quantitative at best and is 
subject to many shortcomings that make bedside assessment in a critical care 
environment fundamentally difficult[17]. Our novel approach provides accurate 
measurements of oxygen saturation, velocity, supply rate, and hematocrit of RBCs 
passing through single capillaries in the microvascular network. While we are able to 
utilize scoring criteria to provide data similar to sublingual measurements, incorporating 
RBC saturations into our sepsis model elucidates a true mechanistic effect of fluid 
administration on tissue oxygenation, which greatly increases the translational ability of 
our approach.  
This paper presents preliminary results of our study investigating the effect of fluid type 
on optimizing clinical hemodynamic targets, while concurrently providing insight into 
the restorative ability of each fluid on the degree of microvascular dysfunction. We report 
for the first time that after induction of sepsis, using a MAP of 75mmHg as our 
resuscitation target, bolus injections of 5% albumin appear to better restore 
macrovascular and microvascular parameters, compared to saline. Despite the ability to 
restore MAP, saline had little effect on both cardiac output and microcirculatory 
perfusion, with endpoints similar to our septic control animals. These preliminary data 
suggest that albumin, administered at the onset of sepsis, is a more effective resuscitation 
fluid in terms of hemodynamic optimization and, in-line with the emerging clinical goal 
of microvascular restoration, may provide a protective effect in reducing the hypoxic 
environment in the vital organs.  
3.2  Methods 
Animal protocols were approved by the Animal Care and Use Committee of the 
University of Western Ontario (see appendix A). Sprague-Dawley rats were used in this 
study; male rats were used exclusively in order to eliminate the effects of the estrous 
cycle[18]. 
A timeline of the experimental protocol is provided (Fig. 3-1). 
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3.2.1  Feces Induced Peritonitis (FIP) 
Peritonitis was induced via intraperitoneal injection of autologous feces (FIP) (0.3 
ml/100g rat of fecal slurry (1.5g feces in 1.5 ml saline)). The fecal slurry was made on the 
day of the experiment. Sham animals received saline (0.3ml/100g rat, 0.9% saline) as 
opposed to FIP slurry. 
3.2.2  Animal Instrumentation 
The rats (100g on delivery) were housed in the animal quarters at the University of 
Western Ontario and acclimatized for 7 days after delivery. For these experiments we 
used our previously developed translational animal model of sepsis. Briefly, on the day of 
the experiment, rats were randomized to FIP, FIP-Saline resuscitated (0.9% Saline, 
B.Braun Medical Inc., Irving, CA), FIP-Albumin resuscitated (Alburex 5, CSL Behring, 
Ottawa, ON), or sham laparotomy groups, and weighed to verify that their mass was 
within experimental range (170-210g). Animals were anesthetized via intraperitoneal 
injection of sodium pentobarbital (6.5 mg/100g body weight), and mechanically 
ventilated at a rate of 73-76 breaths/min with a flow-controlled air mixture of 
30%O2/70%N2. Temperature was monitored using a rectal probe, and maintained at 
37oC. The right carotid artery, and left jugular vein were cannulated to monitor heart rate 
and MAP, and CVP respectively, via attached pulse transducers. Supplementary 
anesthetic, and saline were administered via the jugular catheter, as needed. The bolus 
injection of fluids was also administered via the jugular catheter, as required to maintain 
clinical optimization targets. Cardiac output was measured using a transonic flow probe 
attached to the abdominal aorta between the right iliolumbar artery and the right external 
iliac artery. The incision was then sutured closed in two layers.  
The extensor digitorum longus (EDL) muscle was blunt dissected as previously 
described[19], and reflected onto the stage of a dual-wavelength intra vital video 
microscope. Midline stitches were then removed and peritonitis was induced with an 
intraperitoneal FIP injection. The sham animals received the same volume of saline. The 
muscle was then secured via attached silk ligature at its in situ length, and relative 
orientation, and was isolated from room air using a small rectangle of plastic film (2 x 1 
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cm, polyvinylidene chloride, Saran) The muscle was moistened with 37°C saline (0.9%) 
and a glass coverslip sealed with vacuum grease to isolate the muscle from the external 
environment. 
3.2.3  Dual Wavelength Intra-Vital Video Microscopy 
The acquisition system was an inverted microscope fitted with a xenon lamp for 
transillumination. A beam splitter with a filter cube containing interference filters at 
wavelengths of 442-nm and 454-nm, which allowed for dual-wavelength video capture. 
After allowing the muscle to equilibrate (30 minutes) real-time microvascular blood flow 
video sequences (696 X 520, 21 frames/second) were taken of in-focus capillaries within 
the EDL muscle. Post-processing using the dual wavelength system permitted calculation 
of RBC velocity, supply rate, hematocrit, hematocrit, and oxygen saturations, of the in-
focus capillaries within the EDL muscle as previously described[20, 21].  
3.2.4  Clinical Hemodynamic Optimization Target 
The hemodynamic optimization target that we used for our study was motivated by 
clinical inclusion criteria provided by our collaborative knowledge users. The criteria we 
used in our protocol to begin resuscitation was a MAP <75mmHg. Once the MAP of the 
animal dropped below this threshold 1ml bolus injections of the resuscitation fluid were 
administered into the venous system. This process was repeated as necessary to maintain 
MAP > 75mmHg. Consecutive bolus injections were often needed, however, a 5-minute 
window between injections was used in order to prevent over-resuscitation due to 
response from the previously injected bolus. Bolus injections were never given during the 
recording of the 3-hour videos, to prevent misrepresentation in post-processed capillary 
measurements.  
3.3  Experimental Protocol 
3.3.1  Video Recordings 
After intraperitoneal injection of the FIP (baseline), the physiological status of the animal 
was continuously monitored, as previously outlined. Microvascular blood flow video 
sequences were taken of in-focus capillaries in 10 distinct fields of view (FOV) (one 
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minute recording for each FOV). Recordings were made at baseline (after equilibration), 
3 hours, and 5 hours post-injection.  
3.3.2  Blood Samples 
After the video sequences were recorded 250μl of heparinized arterial blood was 
collected (baseline, 3, 5 hours). Once the sample was collected the blood volume was 
replaced with heparinized saline. To measure systemic blood variables, an iSTAT point-
of-care system was used, along with associated cartridges (CG4+: Lactate, blood gases, 
CG8+: Na, K, iCa, Gluc, Hct, blood gases).  
3.3.3  Capillary Analysis 
Measurement of average velocity, O2 saturation, RBC supply rate, and hematocrit were 
made from the analysis of the post-processed video capture sequences. All in-focus 
vessels, from each field of view, at each time point, were analyzed using the same 
technique. See Appendix B. The capillary bed within the muscle is inherently 
heterogeneous in terms of microvascular geometry, blood flow and oxygen transport. We 
attempted to obtain a representative sample by randomly selecting capillaries in 10 
distinct FOV. It is expected that the impact of sepsis or resuscitation would uniformly 
affect microvascular perfusion, so these data are presented as percent change from 
baseline, as it is more representative of the microvascular alteration over the course of the 
experiment. 
3.3.4  Functional Capillary Density Measurement 
Capillary densities were determined from the captured video sequences by counting the 
number of capillaries that crossed three staggered overlaid test lines (200μm	   each)	  
perpendicular to the direction of the EDL muscle fibers	   as	  described	  previously[22].. 
Capillary density was counted for each field of view, at each time point, and averaged to 
determine the change in capillary density over the course of the septic response. 
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3.3.5  Physiological Data Analysis 
The physiological data collected for the duration of the experiment was analyzed using 
LabChart software. A moving average was used to analyze the collected variable signals 
(MAP, CVP, CO, HR). A 300 second (5 minute) averaging window was chosen, and the 
average of each interval was taken over the course of the experiment (5 hours). This was 
done to eliminate major deviations within the signal in order to extract the physiological 
effect of the insult alone. Stroke volume (CO x HR) and total peripheral resistance 
(MAP-CVP/CO) were calculated at the culmination of the experiment. The positioning of 
the cardiac output probe on the abdominal aorta is subject to variability between animals, 
due to influence of the anesthetic, and the fact that the volume flow measured at this 
anatomical position does not include flow to the brain, brachial arteries, kidneys liver or 
the splanchnic organs. For this reason, percent change in cardiac output was used, as it is 
more representative of the changes that occur over the course of the septic response. For 
this reason stroke volume and total peripheral resistance are also presented as percent 
change, as these calculations are reliant upon cardiac output data.  
3.3.6  Statistical Analysis 
The time plots of the physiological data were not analyzed statistically, and are provided 
for qualitative purposes. In order to analyze the physiological data, box-and-whisker plots 
were made for the 3 time point blocks (baseline, 3 hours, 5 hours) and are presented as 
median and inter-quartile range (IQR). Continuous variable differences between the 4 
treatment groups at the 5-hour timepoint were compared using the Kruskal-Wallis test, 
followed by post-hoc analysis via Bonferri-Dunn test for multiple comparisons. The 
capillary data are presented as mean ± standard error of the mean (SEM). These data 
were analyzed by one-way analysis of variance (ANOVA) with post-hoc Bonferri-Dunn 
test for multiple comparisons. A p-value of 0.05 was considered significant. For 
simplicity, significance is presented for the 5-hour time point only.  
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Figure 3-1 Timeline of study for animal model. Blue arrows indicate the timing of video 
captures, as well as timing of blood collection. Red asterisk indicates administration of 
FIP, and BL indicates the timing of baseline measurement collection. The animal is 
minimally resuscitated with an infusion of saline (0.9%, 0.5 ml/hr), until MAP drops 
below the 75mmHg threshold, at which point, bolus injection of the resuscitation fluid 
are implemented to maintain this parameter. MAP, HR, CVP, and CO are measured for 
the entire observation period. 
3 .4  Results 
The global variables (Table 3-1) were not significant; however the FIP and FIP+Saline 
groups levels are indicative of hyperlactatemia The FIP+Saline and FIP+Albumin groups 
had lower hematocrit, and lower PaO2.. 
Although this is a preliminary study (n=3 per group) the administration of the different 
fluids caused differences in terms of macrovascular and microvascular response. Figure 
3-2 shows the average physiological parameters for each group over the entire course of 
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the experiment. Individual animals in all FIP groups dropped below the MAP threshold at 
some point during the experiment. There was a significant difference in MAP (Fig. 3-3A) 
at 5 hours for the FIP and FIP+saline groups compared to sham-operated control. All of 
the septic animals had decreased MAP compared to baseline. For CVP, FIP+Albumin 
group was significantly decreased (Fig. 3-3B) as compared to the sham-operated animal at 
5 hours. The FIP animal had significantly decreased heart rate from baseline (Fig. 3-3C), 
and as compared to 5-hour sham animals. Both FIP and FIP+Saline groups had 
significantly decreased cardiac output (Fig. 3-3D) compared to baseline. The FIP and 
FIP+Saline groups had significantly increased TPR (Fig. 3-3E) compared to both the 5-
hour sham, and 5-hour baseline measurements, while the FIP+Albumin group had 
significant decreased TPR compared to baseline. Lastly, the FIP and FIP+Saline groups 
had significantly decreased stroke volume (Fig. 3-3F) compared to baseline, and the FIP 
group also was significantly decreased compared to the 5-hour sham. None of the data for 
the raw microvascular data was significant. 
The only data that was significant for the normalized microvascular analysis was a 
significant decrease in stroke volume for the FIP+Saline group compared to baseline 
(Fig. 3-5D). Qualitatively, for the velocity (Fig. 3-5A), oxygen saturation (Fig. 3-5B) and 
stroke volume (Fig. 4D) the FIP and FIP+Saline groups follow a similar trend, declining 
in a linear fashion throughout the course of the experiment. The FIP+Albumin group 
followed a similar trend in these measurements from baseline to 3 hours; however, in all 
3 measurements, the trend reversed and increased from 3 hours to 5 hours. In terms of 
hematocrit (Fig. 3-5C) the FIP and FIP+Albumin groups increased from baseline, whereas 
the FIP+Saline group decreased from baseline. Similarly, there was no significant change 
in the functional capillary density data.  
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   Sham	   FIP	   FIP	  +	  Saline	   FIP	  +	  Albumin	  
n	   2	   2	   2	   2	  
Weight	  (g)	   172.5	   200	   174	   175	  
pH	   7.482	   7.347	   7.333	   7.314	  
PaO2	  (kPa)	   121	   106	   87	   73	  
PaCO2	  (kPa)	   33.6	   40.6	   27.6	   45	  
Glucose	  (mmol/L)	   7.5	   4.25	   4.8	   5.2	  
Lactate	  (mmol/L)	   0.783	   2.165	   2.775	   0.8	  
Hemoglobin	  (g/dl)	   127.5	   159.5	   88	   116	  
Hematocrit(%)	   0.375	   0.47	   0.26	   0.34	  
Additional	  Fluid	  for	  Resuscitation	  (ml)	   N/A	   N/A	   5.5	   3	  
Table 3-1 Arterial blood measurements (via iSTAT) for Sham, FIP, FIP+Saline and 
FIP+Albumin groups. Data shown are averages of 2 animals in each group, 5 hours after 
septic insult. Average fluid required to achieve physiological target are also shown where 
appropriate. 
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Figure 3-2 Physiological parameters of sham-operated, septic (FIP), septic (FIP-Saline 
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Mean arterial pressure, 
(B) Central Venous Pressure, (C) Heart Rate, (D) Cardiac Output, (E) Total Peripheral 
Resistance (F) Stroke Volume. The mean arterial pressure graph has a superimposed line 
(75mmHg) illustrating our hemodynamic optimization target.  
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Figure 3-3 Physiological parameters of sham-operated, septic (FIP), septic (FIP-Saline 
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Mean arterial pressure, 
(B) Central Venous Pressure, (C) Heart Rate, (D) Cardiac Output, (E) Total Peripheral 
Resistance (F) Stroke Volume are displayed for each time point (baseline, 3 hours, 5 
hours) as median  (IQR). *Difference at 5 hours between septic animals and sham (P 
<0.05). #Difference within group between 5 hour and baseline measurement (P<0.05).   
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Figure 3-4 Microvascular parameters of sham-operated, septic (FIP), septic (FIP-Saline 
resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) Velocity (B) Oxygen 
Saturation (C) Hematocrit and (D) Supply Rate are displayed for each timepoint as mean 
and individual animal values. 
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Figure 3-5 Microvascular parameters (normalized to baseline) of  sham-operated, septic 
(FIP), septic (FIP-Saline resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) 
Velocity (B) Oxygen Saturation (C) Hematocrit and (D) Supply Rate are displayed for 
each timepoint as mean and individual animal values. #Difference within group between 
5 hour and baseline measurement (P<0.05).  
  
60 
 
 
Figure 3-6 Functional capillary density measurements of sham-operated, septic (FIP), 
septic (FIP-Saline resuscitated), septic (FIP-Albumin resuscitated) rats (n=3). (A) 
baseline (B) 3 hour and (C) 5 hour functional capillary densities are shown. Capillaries in 
each field of view are categorized as continuous, intermittent, or stopped depending on 
degree of RBC transit. Data are presented as mean ± SEM .  
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3.5  Discussion 
The debate as to which fluid is best used for the resuscitation of septic patients to achieve 
macrovascular optimization has not been resolved[6, 8, 14]. It is well known that early 
fluid resuscitation of septic patients improves survivability; however the effect of 
administered fluid on the microvascular environment is rarely considered[2]. It has been 
shown that microcirculatory dysfunction is a major contributor to global tissue hypoxia, 
which eventually leads to multiple organ failure[1]. Thus, the ability to test common 
clinical therapies aimed at optimizing macrovascular hemodynamic targets, and elucidate 
the associated effect on the microcirculation could provide valuable information with 
important clinical implications. In this preliminary study, we demonstrated the unique 
ability to test the effect of fluid resuscitation on the microvascular environment in a 
translational animal model of sepsis.  
While the data presented are preliminary, the trends in the macro- and the 
microcirculatory environments are encouraging. With our developed translational animal 
model, we are able to consistently replicate the transition from pre-sepsis to sepsis. See 
Appendix C. The FIP animals all exhibited the systemic changes commonly associated 
with an early septic response (drop in cardiac output, increased total peripheral 
resistance) (Figs. 3-2, 3-3). Interestingly, the administration of bolus albumin was able to 
decrease these trends and had an increased cardiac output, and decreased total peripheral 
resistance compared to the 3-hour time point. Albumin resuscitation was also better able 
to maintain blood pressure about 75mmHg, evidenced by the amount of bolus injections 
administered, compared to saline. This makes sense given the properties of albumin, and 
the ability to maintain colloid osmotic pressure. In terms of stroke volume, the FIP, and 
FIP+Saline groups decreased from the onset of sepsis, while the FIP+Albumin group 
followed a similar trend at the 3-hour time point; however, much like cardiac output and 
total peripheral resistance, the trend reversed at the 5-hour time point, leading to an 
increased stroke volume. Taken together, it appears that at the macrovascular level, 
albumin is able to better restore hemodynamic parameters.  
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The trends at the microcirculatory level are similar (Figs. 3-5). In terms of velocity, 
oxygen saturation, and supply rate in the capillaries, both the FIP and FIP+Saline groups 
decline in a linear fashion after initiation of the sepsis. The albumin-resuscitated group 
similarly declined from baseline; however after the 3-hour time point, and the associated 
administration of bolus albumin injections, the trend reversed, and all three parameters 
increased. The hematocrit increased in the FIP and albumin groups, and decreased in the 
saline group. For the FIP group this could be due to vascular leak, which decreases the 
plasma volume. For the FIP+Albumin group, the increase in hematocrit could be 
attributed to the increased velocity and supply rate. 
The trends in functional capillary density (Fig. 3-6) were that in the FIP and FIP+Saline 
groups, there was an increase in intermittent flow capillaries over the course of the 
experiment and a related decrease in continuous flow capillaries. The FIP+Albumin 
group had an increase in intermittent flow capillaries, but reversed this trend at the 5-hour 
time point. These trends are indicative of capillary functionality, as an increase in stopped 
flow capillaries has previously been shown to increase in sepsis[22]. While there was not 
an increase in the amount of stopped flow capillaries for the septic animals, the increase 
in intermittent flow is potentially an early indicator of microvascular dysfunction. In 
order to be able to analyze capillaries quantitatively, there needs to be RBC transit. While 
an increase in the amount of intraperitoneal FIP administered would cause a more severe 
septic response, which would promote an increase in stopped flow capillaries, we would 
have to lose vessels for our hemodynamic and O2 measurements, which are a pivotal 
advantage of our animal model.  
In terms of clinical inclusion criteria, we used a mean arterial pressure of 75mmHg as our 
resuscitation target, which is only one part of sepsis inclusion criteria. Besides mean 
arterial pressure, temperature >38oC or <36oC, respiratory rate >20 breaths/minute or 
PaCO2 <32 mmHg, heart rate>90 beats/min, and WBC count >12,000 cells/mm3 or 
<4,000 cells/mm3 are also considered indicators of sepsis. Due to the use of pentobarbital 
anesthetic we are unable to use time until respirator requirement as a metric of sepsis 
onset, and the respiratory rate is controlled throughout the experiment. We are able to 
take blood samples to measure PaCO2; however, the sample requires 250µl blood draws, 
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making regular sampling over the course of the experiment subject to hemodilution. This 
is the same issue with measuring WBC count regularly. We also maintain internal 
temperature of 37oC over the course of the experiment. In addition, it is clinically 
common to measure mixed venous oxygen saturation, which is difficult in our model due 
to the positioning of the jugular vein catheter. Unlike the carotid artery, blood does not 
passively flow out of the jugular catheter, thus measurement requires drawing the blood 
with a syringe. The clotting nature of blood requires this process to be done very quickly, 
and if the blood is not totally flushed from the line, will risk forfeiting CVP monitoring 
for the rest of the experiment. For these reasons our use of MBP < 75mmHg made the 
most sense given our instrumentation, and the physiological similarity in values as 
compared to a human (Appendix C). 
Although more experimentation with these fluids needs to be done in order to truly show 
fluid resuscitation efficacy, it appears that albumin is a more effective fluid at restoring 
both microvascular and macrovascular targets. Interestingly, although saline was able to 
restore the blood pressure values, cardiac output, and microvascular parameters continued 
to decline, which supports the notion that hemodynamic optimization is not reflective of 
the microvascular environment surrounding in vital organs. Furthermore, the successful 
application of this model and the promising ability of deducing mechanistic effects of 
fluid resuscitation, demonstrate the fidelity of our animal model, and encourages the use 
of this model for future sepsis research applications. Subsequent experiments, and 
additional instrumentation will only further improve upon our animal model, and will 
continually improve translational research and education.  
3.6  Conclusion 
We demonstrated the unique ability to monitor systemic physiological parameters over 
the course of a septic insult, and couple these data to microvascular data in the hindlimb 
muscle. Coupling these measurements we tested clinical fluid resuscitation protocols 
using both saline and 5% human albumin, two of the most commonly used, and 
commonly debated fluids. Our preliminary findings indicate that albumin is better at 
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restoring macrovascular homeostasis, as well as restoring microvascular perfusion and 
oxygenation in sepsis.  
  
65 
 
3.7  References 
1. Otero, R.M., H.B. Nguyen, D.T. Huang, D.F. Gaieski, M. Goyal, K.J. Gunnerson, 
S. Trzeciak, R. Sherwin, C.V. Holthaus, T. Osborn, and E.P. Rivers, Early goal-
directed therapy in severe sepsis and septic shock revisited: concepts, 
controversies, and contemporary findings. Chest, 2006. 130(5): p. 1579-95. 
2. Rivers, E.P., M. Katranji, K.A. Jaehne, S. Brown, G. Abou Dagher, C. Cannon, 
and V. Coba, Early interventions in severe sepsis and septic shock: a review of 
the evidence one decade later. Minerva Anestesiol, 2012. 78(6): p. 712-24. 
3. Rivers, E., B. Nguyen, S. Havstad, J. Ressler, A. Muzzin, B. Knoblich, E. 
Peterson, M. Tomlanovich, and G. Early Goal-Directed Therapy Collaborative, 
Early goal-directed therapy in the treatment of severe sepsis and septic shock. N 
Engl J Med, 2001. 345(19): p. 1368-77. 
4. Dellinger, R.P., M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, S.M. Opal, J.E. 
Sevransky, C.L. Sprung, I.S. Douglas, R. Jaeschke, T.M. Osborn, M.E. Nunnally, 
S.R. Townsend, K. Reinhart, R.M. Kleinpell, D.C. Angus, C.S. Deutschman, F.R. 
Machado, G.D. Rubenfeld, S. Webb, R.J. Beale, J.L. Vincent, R. Moreno, and S. 
Surviving Sepsis Campaign Guidelines Committee including The Pediatric, 
Surviving Sepsis Campaign: international guidelines for management of severe 
sepsis and septic shock, 2012. Intensive Care Med, 2013. 39(2): p. 165-228. 
5. Kruer, R.M. and C.R. Ensor, Colloids in the intensive care unit. Am J Health Syst 
Pharm, 2012. 69(19): p. 1635-42. 
6. Finfer, S., R. Bellomo, N. Boyce, J. French, J. Myburgh, R. Norton, and S.S. 
Investigators, A comparison of albumin and saline for fluid resuscitation in the 
intensive care unit. N Engl J Med, 2004. 350(22): p. 2247-56. 
7. Wilkes, M.M. and R.J. Navickis, Patient survival after human albumin 
administration. A meta-analysis of randomized, controlled trials. Ann Intern Med, 
2001. 135(3): p. 149-64. 
8. Choi, P.T., G. Yip, L.G. Quinonez, and D.J. Cook, Crystalloids vs. colloids in 
fluid resuscitation: a systematic review. Crit Care Med, 1999. 27(1): p. 200-10. 
9. Angus, D.C., J.P. Mira, and J.L. Vincent, Improving clinical trials in the critically 
ill. Crit Care Med, 2010. 38(2): p. 527-32. 
10. Dyson, A., S. Cone, M. Singer, and G.L. Ackland, Microvascular and 
macrovascular flow are uncoupled in early polymicrobial sepsis. Br J Anaesth, 
2012. 108(6): p. 973-8. 
11. Nencioni, A., S. Trzeciak, and N.I. Shapiro, The microcirculation as a diagnostic 
and therapeutic target in sepsis. Intern Emerg Med, 2009. 4(5): p. 413-8. 
12. De Backer, D., J. Creteur, J.C. Preiser, M.J. Dubois, and J.L. Vincent, 
Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care 
Med, 2002. 166(1): p. 98-104. 
13. McIntyre, L.A., D.A. Fergusson, D.J. Cook, B.H. Rowe, S.M. Bagshaw, D. 
Easton, M. Emond, S. Finfer, A. Fox-Robichaud, C. Gaudert, R. Green, P. Hebert, 
J. Marshall, N. Rankin, I. Stiell, A. Tinmouth, J. Pagliarello, A.F. Turgeon, A. 
Worster, R. Zarychanski, and G. Canadian Critical Care Trials, Fluid 
Resuscitation with 5% albumin versus Normal Saline in Early Septic Shock: a 
pilot randomized, controlled trial. J Crit Care, 2012. 27(3): p. 317 e1-6. 
66 
 
14. American Thoracic, S., Evidence-based colloid use in the critically ill: American 
Thoracic Society Consensus Statement. Am J Respir Crit Care Med, 2004. 
170(11): p. 1247-59. 
15. Vincent, J.L., Relevance of albumin in modern critical care medicine. Best Pract 
Res Clin Anaesthesiol, 2009. 23(2): p. 183-91. 
16. Zoellner, H., M. Hofler, R. Beckmann, P. Hufnagl, E. Vanyek, E. Bielek, J. 
Wojta, A. Fabry, S. Lockie, and B.R. Binder, Serum albumin is a specific 
inhibitor of apoptosis in human endothelial cells. J Cell Sci, 1996. 109 ( Pt 10): p. 
2571-80. 
17. Bezemer, R., S.A. Bartels, J. Bakker, and C. Ince, Clinical review: Clinical 
imaging of the sublingual microcirculation in the critically ill - where do we 
stand? Crit Care, 2012. 16(3): p. 224. 
18. Angele, M.K., M.G. Schwacha, A. Ayala, and I.H. Chaudry, Effect of gender and 
sex hormones on immune responses following shock. Shock, 2000. 14(2): p. 81-
90. 
19. Tyml, K. and C.H. Budreau, A new preparation of rat extensor digitorum longus 
muscle for intravital investigation of the microcirculation. Int J Microcirc Clin 
Exp, 1991. 10(4): p. 335-43. 
20. Pittman, R.N., Oxygen transport in the microcirculation and its regulation. 
Microcirculation, 2013. 20(2): p. 117-37. 
21. Japee, S.A., R.N. Pittman, and C.G. Ellis, A new video image analysis system to 
study red blood cell dynamics and oxygenation in capillary networks. 
Microcirculation, 2005. 12(6): p. 489-506. 
22. Lam, C., K. Tyml, C. Martin, and W. Sibbald, Microvascular perfusion is 
impaired in a rat model of normotensive sepsis. J Clin Invest, 1994. 94(5): p. 
2077-83. 
  
67 
 
Chapter 4  
Contributions, Limitations and Future Directions 
4.1  Contributions 
Recently, there has been a call for animal models of sepsis that are more representative of 
the clinical scenario. There is a noticeable disconnect between preclinical experimental 
findings, and successful translation to the clinical environment, which is illustrated in the 
failure of many multi-center clinical trials. While success in human patient cohorts is 
important, animal models remain as essential tools in developing new therapies and 
determining the mechanism of clinical interventions.  
While many models of sepsis are currently in use, each with distinct advantages, there is 
still a need for high-fidelity animal models that can be adapted depending on the needs of 
critical care[5]. 
In addition, the ability to provide macrovascular and microvascular data, in conjunction 
with a controlled septic insult, is of utmost importance, especially considering that the 
microcirculation is being recognized as an important target for early goal-resuscitation 
therapies[15, 33].  
The goal of this thesis was to develop an animal model of sepsis, building on the 
recommendations of ICU physicians, that is more relevant to the clinical septic response. 
We have demonstrated a dual-sided approach that provides concurrent macrovascular and 
microvascular data, over the entire course of a FIP-induced sepsis insult. Our use of FIP 
to induce sepsis allows for a greater degree of control than other more variable models 
such as CLP, which is still considered the gold standard.  The commonality of the CLP 
lies in the ability to replicate the events associated with the early phase of a septic 
response (low CO, high TPR), which our FIP insult is also able to reproduce. The unique 
ability of our model lies in our high-level instrumentation, which provides physiological 
data similar to what would be available for a patient in the ICU.  Our use of a dual-
wavelength camera allowed us to extract valuable quantitative microvascular data, which 
provides insight into the environment that may be surrounding the vital organs. As 
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current clinical microvascular data uses the sublingual microcirculation to assess degree 
of dysfunction, we are able to apply the same principles in an organ remote to the site of 
initial infection. A further advantage of our model lies in the ability to extract oxygen 
saturations for individual capillaries, effectively removing reliance on purely qualitative-
based assessment of microvascular perfusion. This aspect of our model has many 
implications in terms of future applications of the model aimed at determining the 
mechanistic effect of therapeutics. Applying our model in this manner was the secondary 
goal of this thesis.  
The secondary aim of this thesis was to apply our developed model in an attempt to 
address the efficacy of saline and albumin as resuscitation fluids. Guided by our research 
colleagues (Dr. Michael Sharpe, University Hospital, London, ON – Critical Care and 
Anesthesia, and Dr. Alison Fox-Robichaud, McMaster Hospital, Hamilton, ON – Internal 
Medicine, Critical Care) and the Canadian Critical Care Translational Research Group, 
we decided that the first application of our model would test the efficacy of fluid types 
using current clinical diagnostic criteria. In our preliminary study we administered either 
saline or albumin in order to maintain systemic blood pressure of 75mmHg or greater. 
We demonstrated our ability to illustrate the mechanistic effect of fluid type on 
macrovascular and microvascular environment in sepsis. While saline and albumin were 
both able to restore blood pressure, the trends at the 5-hour timepoint for other systemic 
parameters were different.  Saline was unable to improve cardiac output, stroke volume, 
and maintained increased TPR, while albumin had the opposite effect, increasing cardiac 
output, and stroke volume, and decreasing TPR. The situation at the microvascular level 
was similar. In terms of oxygen saturation, velocity, and supply rate, saline animals 
declined over the course of the response, while the animals in the saline group increased 
after administration of an albumin bolus. These results suggest that albumin may provide 
a therapeutic benefit beyond hemodynamic optimization, and is more effectively at 
restoring systemic homeostasis than saline.  
In addition to providing evidence for the use of albumin in fluid resuscitation, we 
developed a fluid resuscitation model of sepsis that can be tested in conjunction with 
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other therapies, co-morbidities, and disease severities to further increase the translational 
ability of our model.  
This translational tool has several potential applications, and addressed many of the 
drawbacks of previous models that have been recently examined[1]. This model has 
several potential additions that will strengthen its integrity, and it is well set-up for 
modifications, as needed, to meet the demands of critical care research.  
4.2  Limitations/Additions 
The limitations of these studies are mainly technical, and involve the instrumentation of 
the rat in our protocol. Some of these were alluded to in the discussion of the previous 
chapters.  
Since we are mechanically ventilating the rat with a preset ventilation rate (generally 73-
76 breaths/min), applying a positive end expiratory pressure (PEEP) would be a valuable 
addition to our model. Currently we relied on the PaO2 and PaCO2 values measured via the 
iSTAT cartridges and arterial blood samples to determine the ventilation rate, but these 
measurements provide little indication about respiratory distress. By changing the 
ventilator that we use we would be able to apply a PEEP within our animals. The 
application of PEEP would be valuable to ensure airways stay open, which would offset 
acute respiratory distress syndrome (ARDS), and respiratory failure due to edema 
formation.  
Second, catheterization of the bladder to monitor urine output is another potential 
addition to our model, which would provide another measurement common in clinical 
practice.  While we did not include this procedure in our current protocol, the technique 
to catheterize the bladder of a male within the peritoneal cavity has recently been 
developed[4]. Due to our use of pentobarbital anesthetic this catheterization technique is 
necessary, as urine does not passively flow, as the central nervous system is depressed. 
This technique would be a valuable addition to the model, and would provide insight into 
the degree of kidney dysfunction in the rat, adding another aspect of clinical inclusion 
criteria. We make a midline incision for the implantation of the cardiac output flow 
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probe, which makes the bladder catheterization accessible. The reason that we did not 
include this in the original model is due to the difficulty of surgery, and the fact that the 
suggestion of this technique came after several animal experiments were completed. Due 
to the increased inflammation that would occur due to the extra surgery, we did not want 
to introduce unnecessary variability into our experiment.  
Next, measurement of mixed venous saturation would improve upon the clinical 
relevancy of our model. Mixed venous oxygen saturation is another target common to 
early-goal directed therapies, and is often used as a metric of imbalance between oxygen 
delivery and systemic oxygen consumption[3]. Although we rely on MAP to guide our 
resuscitation protocols, it would be worthwhile to monitor consistent changes in mixed 
venous oxygen saturation to get a sense of how accurate reliable it is as a tissue perfusion 
surrogate. Continuous measurement of venous oxygen saturation is possible using an 
implanted fiber-optic catheter, and has been demonstrated in newborn infants[5]. Barring 
the lack of instrumentation in our lab, we could adapt this technique for use in our model, 
as we already catheterize the jugular vein, thus extra surgery would not be required.  
Measurement of white blood cell count during the experiment would be another valuable 
addition to our model in terms of clinical indications of sepsis (WBC ct. >12 or <4). 
Performing a complete blood count at each timepoint could provide information about 
platelets as well, which is another measurement common to the bedside. Currently this 
test is not performed due to time constraints in the experimental protocol, however could 
be added with the help of additional personnel.  
Another addition that could be useful in terms of our model would be if we had the 
ability to monitor the amount of applied heat required to maintain core body temperature 
of 37OC. In the clinical setting patients becoming either hypothermic (temp <36OC) or 
hypothermic (temp > 38OC) is an indicator of systemic inflammation. Monitoring the 
amount of applied heat would provide insight into the temperature control abilities of 
septic animals.   
In addition, given that we continuously monitor systemic parameters over the course of 
the septic insult, it would be interesting to look at heart-rate variability. Heart-rate 
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variability analysis can provide insight into myocardial distress, which could provide 
insight into the cardiac output trends that are seen in the septic animals. This data has 
already been acquired, and thus analysis of the data is possible to determine the effect of 
sepsis on heart rate variability in our model. This also has clinical implications as heart-
rate variability can easily be measured in human patients, and may have predictive 
effects.  
Lastly, at the end of the experiment, the vital organs were harvested (kidney, spleen, 
liver, skeletal muscle, diaphragm, lung, heart, and brain) and stored for future use. These 
tissues could be used for genomic analysis in order to measure gene expression in sepsis. 
Our institution has the infrastructure to analyze the entire genome of the rat (London 
Regional Genomics Centre, Robarts Research Institute, London, ON). This analysis could 
provide valuable information about which genes are upregulated in sepsis, and how the 
administration of fluids or therapeutics affects this regulation. This also has clinical 
implications as patient blood samples are often taken in an attempt to detect early 
markers of sepsis (e.g. IL-6, TNF-α), which can be used to aid in therapeutic 
decisions[6].  
4.3  Future Work 
In terms of future work, there are several potential experiments that involve applications 
of our model.  
As was previously alluded to in the introduction of this thesis, the developed central 
model permits adaptability and introduction of co-morbidities is a logical next step 
application. Since septic patients commonly have co-morbidities, the ability to test the 
septic response in a variety of cases would provide valuable insight in terms of patient 
screening, and illustrate if specific cohorts of patients are better suited to specific 
therapies. For instance, using a diabetic animal, or an animal with cardiovascular disease, 
would provide valuable information about a common clinical comorbidity present in 
septic patients.  
72 
 
It also follows, since the preliminary application of our model was to test albumin and 
saline, that we could also test other fluids, or administer blood transfusions. In this way 
we would be able to deduce which fluid best achieves clinical targets, as well as restoring 
microvascular perfusion. Along the same lines, testing concomitant therapies would be 
another useful application of this model and would improve clinical adaptability, as 
patients commonly receive more than just fluids for treatment (e.g. vasopressors, 
inotropic agents, antibiotics)[7]. 
It would also be valuable to demonstrate the validity of our use of the EDL as 
representative vasculature in the vital organs. It would be valuable to use near infrared 
spectroscopy (NIR) in easily accessible vital organs (kidney, brain) in order to assess 
changes in oxygen saturation over the course of the septic response.  
Since platelet aggregation is associated with the inflammatory response, the ability to 
visualize platelets in conjunction with our dual-wavelength technique for capillary 
oxygen saturation measurements would provide valuable information. This would be 
especially useful for fluid resuscitation, as albumin is believed to have anti-inflammatory 
properties, which this technique would be able to visualize. This could be accomplished 
through the use of spinning disc confocal microscopy, and fluorescent labeling of 
platelets. After the dual-wavelength videos were captured, the cameras could be switched 
to the fluorescent channel, and the platelets in the same channel could be visualized.  
Furthermore, as sepsis is associated with endothelial dysfunction, which causes fluid to 
leak out of the vasculature, it would be interesting to be able to monitor the degree of leak 
in sepsis, and compare the effect that fluid resuscitation has on edema formation. Using a 
dye such as Evans blue would permit this measurements, as it can be injected into the 
animal ~2 hours before sacrifice (which corresponds to onset of sepsis in our model and 
after the animal is sacrificed, the tissues could be homogenized, and the dye 
concentration determined using a spectrometer. This experiment would provide insight 
into the areas of the animal that are most susceptible to vascular leak, and allow us to see 
where resuscitation fluid was collecting. This experiments would further our comparison 
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between resuscitation fluids, as the interaction of specific fluids and the edematous tissue 
could be considered.  
Lastly, this model could serve as a valuable education tool, as we were able to effectively 
create a miniature ICU. Clinicians or residents hoping to gain experience in treating a 
septic patient would be able to obtain real-time training, and would be able to intervene, 
as they deem necessary, based on the same parameters that are available at the bedside.   
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Appendix B: Camera Set-Up, Flow-Probe Measurement 
Dual-wavelength intra-vital video microscopy 
In our experiment we use dual wavelength microscopy to take advantage of the 
differences in absorption spectra of oxy- and deoxyhemoglobin at specified wavelengths 
(Fig. 4-1).  The extraction of capillary SO2 from the dual-wavelength capture is based on 
the equation for the optical density of whole blood at a particular wavelength given by: 
 
𝑂𝐷! = 𝜖!! 𝐻𝑏𝑂! 𝑑 + 𝜖!! 𝐻𝑏 𝑑 (1) 
 
Where 𝜖!! is the extinction coefficient of oxyhemoglobin at the selected wavelength, 𝜖!! is 
the extinction coefficient of deoxyhemoglobin at the same wavelength, 𝐻𝑏𝑂!  is the 
concentration of oxyhemoglobin,   𝐻𝑏 is the concentration of deoxyhemoglobin, and d is 
the path length of light. 
By measuring the optical density in our video captures images at two wavelengths (442-
nm –large absorption difference, 454-nm – no absorption difference) we can calculate the 
ratio of the optical densities, and hence the oxygen saturation via the equation: 
𝑆𝑂! = 𝑚   𝑂𝐷!𝑂𝐷! +   𝑏 (2) 
 
where 𝑂𝐷! is the optical density from (1) where there is a large difference in absorption 
(442-nm) , 𝑂𝐷! is the optical density from (1) where there is no difference in absorption 
(454-nm), and the slope, m, and intercept, b, can be calculated by substituting the 𝑂𝐷! 
and 𝑂𝐷! in the form of (1) and the fact that 𝑆𝑂! = [!"#!][!!]  that is, the concentration of 
oxyhemoglobin divided by the total concentration of hemoglobin[1]. 
77 
 
White light from a xenon light source transilluminates the capillary network, and the 
image is duplicated using a beam splitter, with band-pass interference filters for the 
selected wavelength (Fig.4-1), and subsequently captured with two separate digital 
cameras. The images are then post-processed to generate functional images by methods 
developed by Japee et. al. [2]. 
The functional images are used by proprietary software developed in our laboratory to 
trace the in-focus capillary and create space-time images (S/T images). These images are 
created based on the location of the capillary wall, and the location of the RBCs within 
the capillary column. The space-time image is a time series plot of the movement of 
RBCs through the capillary over the course of the video capture. The created plots 
illustrate the change in location of RBCs in the capillary with respect to time, and can be 
used to measure RBC velocity (µm/s) in capillaries based on the frame-by-frame 
displacement of RBCs and plasma gaps over the course of the video capture. Supply rate 
(# of cells/s) can also be deduced based on the velocity of the RBCs in the column and 
the lineal density (RMCs/mm), which is based on spatial average of optical density over 
the capillary length. The calculations are carried out using proprietary analysis software 
developed in our laboratory that utilizes previously developed techniques to extract 
capillary data for analysis of the microvascular environment [3]. The measurements that 
we consider include: velocity, oxygen saturation, supply rate, and capillary diameter. A 
pictorial representation of capillary data extraction is provided (Fig. 4-2). 
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Figure 4-1 Absorption spectra of human hemoglobin. The superimposed lines indicate 
the wavelengths that our camera capture system utilizes. The 454-nm wavelength is 
isosbestic, and the 442-nm wavelength is differentially absorbed by oxyhemoglobin 
(HbO2) and deoxyhemoglobin (Hb). 
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Figure 4-2 Experimental camera capture, and analysis set-up. During the experiment, 
dual-wavelength intra vital video microscopy is used to monitor capillary blood flow in 
the hindlimb muscle of the rat. The dual wavelength capture (20X) is then post-processed 
to create SAD images, which are used by the vessel selection GUI to trace the in-focus 
capillaries, and create space-time (S/T) images. The S/T images are then used by the 
vessel analysis GUI to calculate changes in velocity, hematocrit, supply rate, and oxygen 
saturation over time, using the data contained in the S/T image. This process is repeated 
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for the in-focus capillaries in 10 fields of view to assess the global tissue microcirculatory 
environment. 
Transonic Flow Probe Cardiac Output Monitor 
The flow probe that was used to monitor cardiac output was a Transonic 2PSB (2mm) 
probe. The probe head consists of two ultrasonic transducers attached on a cuff that are 
positioned on one side of the vessel being monitored. The cuff on the probe head is 
associated with a metal reflector that is fixed in place on the side of the vessel opposite 
the transducers. The reflector acts to redirects the ultrasound signal emitted from one of 
the upstream transducers, through the vessel to the upstream transducer. The time it takes 
the signal to traverse this path is associated with the flow of the vessel within the cuff 
(Fig. 4-3) 
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Figure 4-3 Schematic representation of transonic flow probe used to monitor cardiac 
output. The transducer heads emit a wide ultrasound beam, passing signals back and forth 
to monitor the transit time in the upstream and downstream directions. The difference in 
these measurements reflects the volume flow of the vessel.  
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Both upstream, and downstream transit time measurements are made, which is carried out 
by reversing the transmit-receive sequence between the transducer heads. The output 
cardiac output signal is the difference of the upstream and downstream transit time, as the 
upstream signal is going against the “current”, while the downstream signal is going with 
the “current” thus each metric is needed for signal accuracy. Each transducer emits a 
wide-beam signal, which ensures that the volume flow calculation is accurate. The fact 
that the beam intersects the vessel twice (once on transmission, and once on receiving 
end) decreases the effect of diameter differences and vessel alignment issues, thus 
allowing for reliable implantation and measurements. 
There are a few limitations to the use of the cardiac output probe. These include the 
placement of the probe anatomically, and the use of anesthetic. Since cardiac output is a 
measure of the total volume of blood pumped from the heart per minute, the further away 
from the aorta the greater the misrepresentation of the measurement. Thus our use of 
measurement on the abdominal aorta does not include flow to the brain, or flow in the 
brachial arteries and forelimbs. Next, it has been shown that pentobarbital anesthetic 
depresses cardiac output in rats, and thus it will cause cardiac output to be lower than 
expected. For these reasons it makes sense to measure relative change in cardiac output 
from baseline, rather than attempting to compare cardiac outputs across groups due to the 
high potential for confounding variables. 
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Appendix C: Protocol Modifications 
The first chapter describing the development of the animal model underwent several 
protocol modifications. This appendix will describe these modifications, the associated 
problems with each objective, and the most effective resolutions. This appendix aims to 
mitigate these obstacles for trainees hoping to utilize this animal model in the future. 
Modification 1 – Non Fluid-Resuscitated CLP 
The first objective in the development of this model was to fully instrument the animal in 
order to consistently obtain macrovascular measurements (MAP, HR, CO, CVP, Urine 
Output). Next, we initiated sepsis using the CLP method. The EDL was then blunt-
dissected as described in Chapter 2, and the animal was transferred to the microscope 
stage. The total number of rats used in the development of this preliminary model was 
eighteen (n=18). The number of animals attributed exclusively to each challenge is 
indicated.  
Challenges 
Probe (nprobe = 6): The placement of the flowprobe was the source of several issues as 
manipulation of the inferior vena cava is a fragile process. The process of separating the 
connective tissue that attaches the abdominal aorta and the inferior vena cava is difficult 
and requires careful surgery. Furthermore, upon separation of the membrane the direction 
that the flowprobe cuff encircles the abdominal aorta is important. Both of these issues 
were considerable sources of difficulty in the preliminary stages of this model and were 
addressed as follows: 
1) To separate the membrane between the inferior vena cava and the abdominal 
aorta, the first step is to use cotton swabs to separate the superficial membranous 
tissue. Once this is complete, blunt, curved forceps must be used to slightly pick 
up the abdominal aorta, from the right (anatomical left) side. The forceps tips 
should be seen through the connective tissue (between the vena cava and 
abdominal aorta), when viewed through a surgical microscope. Continuing to use 
the surgical microscope, a pair of serrated straight forceps must be used from the 
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left (anatomical right) side to tease away the connective tissue, in between the 
vena cava and abdominal aorta, with the majority of the force applied to the tips 
of the blunt curved forceps lying underneath. The force must be applied to the tips 
of the forceps favoring the left side, towards the vena cava, as force in the 
opposite direction (towards the abdominal aorta) will cause the vena cava to tear, 
effectively ending the experiment.  
2) Once a hole is made in the membrane, the process should be continued vertically 
until the hole is big enough to fit the flowprobe cuff. After the hole is made, the 
flowprobe cuff must encompass the abdominal aorta by first being inserted 
through the hole, underneath the aorta, and exiting out the right (anatomical left) 
side. This specific direction is needed such that when the animal is rotated on the 
stage the aorta will fall into the probe head, and will not slip out when the animal 
is transferred to the stage.  
CLP (nCLP= 4): The CLP surgery was the source of problems, as the procedure requires 
manipulation of the cecum, tying off of the supplying blood vessels, perforation of the 
membrane, and palpation of the cecum to release fecal contents. Besides the surgical 
challenge, it is difficult to exactly replicate the amount of feces that is extruded. 
Furthermore, the surgery is not possible to perform on the microscope stage, and thus the 
time between initiation of insult, and transfer to the stage is sufficient such that true 
baseline measurements cannot be obtained. Due to this transfer time, the initial 
measurements were made at least one hour after the initial insult, and thus do not 
represent a true baseline. This issue was addressed via the use of FIP instead of CLP to 
induce sepsis. Using a FIP model allowed us to transfer the animal to the stage, and then 
administer the initial insult, significantly reducing the time between insult and baseline. 
Adapting the insult in this way provided us with baseline measurements that were as 
close as possible to a baseline.  
Urine Output (nUrine=4): As urine output is used clinically as an indicator of renal 
failure, we attempted to catheterize the bladder of the rat in order to add this 
measurement to our model. This surgery is invasive and it was difficult to find a detailed 
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protocol describing this method. Due to several failed surgical attempts, and the 
associated termination of data acquisition, the catheterization of the bladder was 
abandoned as an addition to the model. Further training may be required in order to add 
this measurement to the model. 
Video Recordings (nVideo=18*): The video recordings are an integral part of our model 
because they allow us to monitor changes in the microcirculatory environment in the 
EDL over the entire course of the septic insult. While the protocol modifications 
eventually led to baseline video captures immediately following septic insult, we 
eventually realized that we needed to add a middle timepoint in order more effectively 
track the progression of sepsis at the microcirculatory level. *Note: due to the fact that 
the video capture protocol does not affect animal survivability, this n-value indicates the 
number of animal experiments that were carried out without a middle (3-hour) timepoint. 
Conclusion  
In developing this preliminary model we realized the importance of a true baseline when 
considering the septic response. We also realized the importance of consistent placement 
of the abdominal flowprobe to prevent premature termination of the experiment due to 
the surgical procedure. We also realized the difficulty required to obtain urine output 
measurements, and thus sacrificed this addition to the model. Lastly, we realized the 
importance of the 3-hour timepoint in order to better track the microcirculatory response 
to the septic insult. 
Modification 2 – Resuscitated FIP Model 
The second objective after the initial development of the model was to begin 
implementing clinically relevant resuscitation strategies upon diagnosis of sepsis. This 
secondary protocol underwent several modifications regarding the severity of the initial 
insult (FIP), the criteria for diagnosing our animal as septic, and the procedure for 
providing fluids to the animal. The total number of rats used in the development of this 
model was eighteen (n=18). The number of animals attributed exclusively to each 
challenge is indicated.  
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Challenges 
Sepsis diagnosis (nDiagnosis=4): The diagnosis of our animals as septic was an important 
addition to this model, and was based on input from ICU physicians. In the first stages of 
this model, the animal was considered septic at the 3-hour timepoint (not based on 
systemic parameters). This protocol was adapted such that sepsis diagnosis was based on 
mean arterial pressure dropping below 75mmHg consistently for 5 minutes. This 
adaptation was very important to increase clinical relevance, as we introduced sepsis 
diagnosis based on common clinical inclusion criteria. The clinical inclusion criteria is 
MAP < 65 mmHg. The reason for the increase used in our model is explained in the next 
section regarding the severity of the FIP insult. Briefly, animals in the untreated FIP 
group would not survive to the 5-hour timepoint if the insult was severe enough to drop 
blood pressure below 65 mmHg around the 3-hour timepoint of the experiment. This 
adaptation was also very important in terms of guiding our fluid-resuscitation strategy. 
We would begin administering fluids to animals in the treatment groups upon diagnosis 
of sepsis, and would continue to provide fluids until the animal’s blood pressure could be 
maintained (MAP> 75 mmHg). 
Severity of FIP (nSeverity=10): The severity of the initial insult had to undergo continual 
modification as the FIP animals had to become septic, and also survive until the 5-hour 
timepoint. This process was especially difficult in the non-resuscitated FIP group, as the 
untreated animals would rarely survive until 5 hours if sepsis was diagnosed around the 
3-hour timepoint. This step in the protocol involved several modifications to the volume 
of the FIP insult; too little insult would result in a non-septic animal, whereas too large of 
an insult would cause the premature termination of the experiment. Eventually an 
effective dose for the sake of our experimental protocol was realized, which is presented 
in Chapter 2. 
Gradual vs. Bolus Fluid-Resuscitation (nGradual=4): For the animals in the resuscitation 
group, we initially began resuscitation via a gradual infusion of fluid, rather than a bolus 
injection. Upon discussion with our collaborators (ICU physicians) we decided that bolus 
injections were more clinically relevant. Thus the final modification to the protocol was 
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to resuscitate the animals to achieve the clinical target (MAP > 75 mmHg) using 
successive 1 ml bolus injections as needed.  
Conclusion 
In the development of this secondary model we realized the importance of diagnosing 
sepsis based on clinical criteria. We also determined that MAP < 75 mmHg was effective 
to use as our sepsis inclusion criteria. This method also helped to ensure that our fluid-
resuscitation strategy was based on a physiological parameter, and the animals were 
treated consistently between groups. These modifications also led to the most effective 
FIP insult volume such that the animals became septic during the experiment, but the 
untreated animals could survive until the 5-hour timepoint. Lastly, the final modification 
enhanced the clinical similarity of our resuscitation protocol, and we determined that 
bolus injections should be used to fluid resuscitate. 
Final Model – Translational FIP Model of Sepsis  
Once all of the obstacles mentioned above were overcome, we decided our protocol was 
clinically relevant and began applying our model to test the efficacy of fluid type on the 
macrovascular and microvascular environment in a rat FIP model of sepsis. The number 
of animals included in the final model was twelve (n=12) and are presented in this thesis.  
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